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Abstract
Insertions and deletions (indels) in the HIV-1 gp120 variable loops modulate sensitivity to
neutralizing antibodies and are therefore implicated in HIV-1 immune escape. However, the
rates and characteristics of variable loop indels have not been investigated within hosts. Here, I
report a within-host phylogenetic analysis of gp120 variable loop indels, with mentions to my
preceding study on these indels among hosts.
We processed longitudinally-sampled gp120 sequences collected from a public database (n
= 11,265) and the Novitsky Lab (n=2,541). I generated time-scaled within-host phylogenies
using BEAST, extracted indels by reconstructing ancestral sequences in Historian, and esti-
mated variable loop indel rates by applying a Poisson-based model to indel counts and time
data.
Variable loop indel rates appeared higher within hosts than among hosts in subtype C. Our
findings improve understanding of indel evolution in HIV-1 gp120 and enable the evaluation
of models describing indels, which I present as work in progress.
Keywords: HIV-1, gp120, env, variable loops, indels, indel rates, evolution, phylogenetics,
immune escape
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Lay Summary
The Human Immunodeficiency Virus (HIV) attaches to our immune cells using a protein on
its surface called gp120. The nucleotide sequence that produces the gp120 protein undergoes
numerous changes (mutations), with one type being the insertion or deletion of nucleotides
(indels). Indels are most frequently found in five specific regions of the gp120 nucleotide
sequence, or gene, that produce five sugar-covered loop structures (V1-V5) on the surface of
this protein, referred to as “variable loops”. Since gp120 is exposed on the surface of HIV,
the human immune system commonly designs cells and proteins that target key patterns on the
gp120 variable loops in order to detect and eliminate HIV. Importantly, indel mutations can
change the shapes, lengths, and sugar positions of the gp120 variable loops, thereby altering
the same targeted patterns on these loops until they become unrecognizable to the immune
system. This process, known as “immune escape”, occurs repeatedly during HIV infection,
allowing the virus to remain unaffected by the immune response and continue to cause disease.
Rates of mutations provide an indication of how quickly an organism, or virus, can change
itself to adapt to its environment, like in the process of immune escape in HIV, for example. In
the gp120 variable loops, indels are involved in immune escape; however, indel rates have not
been studied in these regions. This work provides the first estimates of indel rates in the gp120
variable loops of HIV by using computer software to estimate the amount of historical time
between different virus samples. I first estimated variable loop indel rates at the population
scale (among hosts) by analyzing one HIV nucleotide sequence per person worldwide. My
main study then estimated indel rates by analyzing multiple sequences collected from a single
individual (within hosts). I found that indel rates appear higher within hosts than among hosts.
This work contributes to a better understanding of an important type of mutation within the
gp120 variable loops that helps HIV adapt to our immune system. It does this by quantifying
how frequently indels occur and their contributions to both variable loop changes and immune
escape.
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Chapter 1
Background and Context
1.1 Human Immunodeficiency Virus
The human immunodeficiency virus (HIV) is a highly diverse and rapidly-evolving virus,
which is the causative agent of Acquired Immune Deficiency Syndrome (AIDS). HIV orig-
inates from the closely-related Simian Immunodeficiency Virus (SIV) found in various non-
human primate species [1]. Specifically, reports suggest that there were multiple independent
transmission events — the transfer of an infectious entity from one host to another — of SIV
in these primate species to human hosts in West and Central Africa [1]. These transmission
events generated multiple genetically-distinct forms of HIV that have been classified into two
types (1 and 2) and further stratified into multiple groups per type [1]. HIV type 1 (HIV-1),
which is the focus of this work, is more pathogenic — or more efficiently causes disease — and
is suggested to originate specifically from the strain of SIV found in the chimpanzee species
Pan troglodytes troglodytes [2, 3].
The HIV-1 genome, a sequence of roughly 9,200 nucleotides, contains 9 distinct genes
that encode all the proteins this virus needs to function [4]. This genome is highly compact
with minimal non-coding sequence amidst these functional genes, meaning that changes to its
genetic sequence, or mutations, can often change the virus’ biological characteristics, or phe-
notype [4, 5]. As a retrovirus, HIV is classified by its conversion of ribonucleic acid molecules
(RNA) into deoxyribonucleic acids (DNA), a process that contradicts the standard “forward”
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flow of genetic information in the central dogma of biology: DNA is used to create RNA, which
generates proteins [6]. Further explanation of this process and its implications will come later.
Of the four distinct groups within HIV-1 (M, N, O, and P), group M (main) is responsible
for the current global pandemic, accounting for roughly 95% of HIV cases worldwide [7].
These HIV types and groups differ considerably in their genetic sequences and fittingly exhibit
corresponding differences in their viral characteristics [8]. For example, HIV-1 group M has
an approximate 100-fold higher fitness — an organism’s capacity to successfully replicate in
a specific environment — in human cells in vitro than either HIV-1 group O or HIV type 2,
which has been suggested to contribute to its widespread prevalence [8]. As of 2018, the
HIV-1 pandemic was infecting approximately 38 million people and has taken the lives of an
estimated 32 million others since it began [9]. Despite improvements in therapeutic treatment
and outbreak management, an estimated 1.7 million new HIV-1 infections and 770,000 HIV-
related deaths were reported in 2018 alone, indicating potential for significant improvement
regarding the prevention and treatment of this virus [9, 10].
1.2 HIV-1 Genome and Structure
HIV is a single-stranded positive sense RNA retrovirus, whose viral particle is comprised of a
protein core surrounded by a lipid membrane derived from the human immune cells it infects
[11]. Within the HIV-1 genome, there are three genes that encode for structural and enzymatic
protein products: gag, pol, and env [11]. All three of these genes encode multiple protein
products that are initially translated as polyprotein precursors and must be cleaved by a protease
to be activated [11].
The gag gene encodes four proteins that are primarily responsible for forming the structures
of the HIV particle. These structures include the matrix supporting the outer lipid membrane
(matrix; p17), the protein shell of the internal viral core (capsid; p24), and the protein com-
plexes encasing the copies of viral RNA (nucleocapsid; p9 and p6) [11, 12].
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The pol gene codes for the reverse transcriptase (RT), integrase, and protease enzymes that
are responsible catalyzing the reverse transcription of viral RNA to viral DNA, the integration
of viral DNA into the host genome, and the cleavage of viral proteins, respectively [11, 12].
Thirdly, the env gene encodes two proteins that comprise the envelope spike protein complexes
embedded in the lipid membrane of HIV-1.
These proteins, gp41 and gp120, are more specifically referred to as glycoproteins, as
they are modified with the attachment of carbohydrate complexes composed of multiple sugar
molecules called glycans [13]. Glycans are critical to the function, folding, and stability of the
two env glycoproteins and will be discussed in more depth later [13, 14]. The gp41 anchor
glycoprotein uses transmembrane protein structures to embed itself in the viral lipid membrane
where it remains relatively hidden from the extracellular environment [15]. The gp120 glyco-
protein, which is the focus of this work, attaches on top of gp41 using noncovalent interactions
where it is fully exposed to the extracellular environment [16, 17]. Importantly, the sequence
of gp120 is segmented into five conserved regions (C1-C5) that comprise the protein’s inte-
rior, and five variable regions (V1-V5) that form disordered loop structures on its exterior [18].
Each protein spike consists of three copies of gp120 and three copies of gp41 bound together
in a trimeric complex which, as a whole, allows HIV-1 to attach to and enter susceptible target
cells [16, 17].
The remaining genes in the HIV genome code for non-structural regulatory and accessory
proteins that perform various functions that support viral infection. These functions include,
but are not limited to, enhancing the efficiency of viral transcription (tat), facilitating nuclear
import (vpr) and export (rev) of viral components, suppressing intracellular (vif ) and extra-
cellular (nef ) antiviral mechanisms, arresting the cell cycle (vpr), and degrading interfering
proteins (vpu) [11, 19–22].
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1.3 HIV Replicative Cycle
1.3.1 Binding and Entry
As a retrovirus, HIV undergoes a unique and complex replicative cycle dependent on the cel-
lular machinery located within susceptible cells. The first stages of this process are to bind
and enter a target cell, which are mediated by the envelope spike complexes on the HIV-1
lipid membrane. Target cell attachment of HIV-1 requires the binding of two receptors: the
primary CD4 surface receptor and a coreceptor. Specifically, gp120 first attaches to the CD4
receptor via its binding site, which induces a conformational change in gp120 and causes ex-
posure of the coreceptor binding site [17]. This enables subsequent binding of an essential
coreceptor from the seven-transmembrane chemokine receptor family [17]. At this point, the
protein interactions between gp120 and both surface receptors induce a series of conforma-
tional changes in the spike complex that enable viral entry [23]. More specifically, gp41 first
adopts an intermediate conformation that allows it to insert its hydrophobic N-terminal fusion
peptide into the target cell membrane [23]. From this stage, gp41 will bring the virus and cell
membranes into close proximity and expand the initialized fusion pore by folding several of
its helical structures together [23]. The contents within the viral protein core are then released
into the cytoplasm of the susceptible immune cell as the capsid proteins dissociate. This leaves
behind the reverse transcription complex, consisting of two copies of the HIV RNA genome
held within nucleocapsid complexes, the RT enzyme and integrase enzymes encoded by the
pol gene, and the Vpr protein [11].
1.3.2 Reverse Transcription
The next stage in the replicative cycle is reverse transcription of the viral RNA genome into
viral DNA. Briefly, this process involves generating a copy of negative-sense viral DNA from
RNA, degrading the original RNA sequence, and synthesizing positive-sense DNA from the
negative-sense strand [11]. When complete, this produces the pre-integration complex [11]. It
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is important to mention here that the RT enzyme does not have 3’ to 5’ exonuclease activity
to proofread incorporated base pairs like other eukaryotic polymerases. This means that the
reverse transcription process is highly error prone, reportedly introducing between 1.4 and
3.4 ×10−5 misincorporated nucleotides per site each time it replicates [24, 25]. In fact, other
sources estimate this rate reaching as high as 4 ×10−3 mutations/nucleotide/replication in vivo
[26]. For reference, these retrovirus mutation rates are between a thousand- and a million-fold
higher than the mutation rates of eukaryotic organisms, which exhibit between 10−8 to 10−11
mutations/site/replication [27].
1.3.3 Integration
At this point, the pre-integration complex, consisting of reverse transcribed viral DNA, inte-
grase enzymes, matrix protein, viral protein R (Vpr), and nucleocapsid proteins, is transported
across the nuclear membrane [28]. Viral protein R and the phosphorylated matrix proteins both
play critical roles in this process [28]. Once in the nucleus, integrase cleaves host DNA and
subsequently inserts the viral DNA into the gap, now being referred to as proviral DNA [28].
1.3.4 Assembly of Virions
The proviral DNA is then transcribed to viral mRNA using the host RNA polymerase II en-
zyme, similar to other human genes in the genome [11]. which is amplified greatly after trans-
lation of the Tat protein [11]. Next, viral RNA is shuttled out of the nucleus with the help of the
Rev protein, followed by viral protein translation and cleavage in the cytoplasm [11]. Finally,
all viral proteins, including two packaged copies of the viral RNA transcripts, are transported
to the cell membrane where aggregate together and bud off into a new HIV viral particle [11].
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1.4 Susceptible Cells & Tropism
HIV infects cell populations that express the CD4 surface receptor protein, which include den-
dritic cells (DCs), macrophages, and importantly, helper T cells [29]. There are also other
less common cell types that are susceptible to HIV based on their expression of CD4, such as
microglia in the brain [30]. While HIV has generally been found in all of these cell types, a
given strain of HIV cannot bind to all of these cell types with the same efficiency and typically
exhibits preference for one population. The different tendencies of HIV-1 to infect specific
cell types are modulated by the virus’s two possible tropisms, or different abilities to infect
specific target cells. The viral tropisms of HIV-1 are associated with the virus’ use of two
different coreceptors belonging to the seven-transmembrane chemokine protein family: the
CC-chemokine receptor 5 (CCR5), and the CXC-chemokine receptor 4 (CXCR4) [31, 32].
The R5 (or M-tropic) HIV strain primarily uses the CCR5 coreceptor for entry, allowing it to
infect macrophages and memory T cell populations [31, 32]. The second tropism, namely the
X4 (or T-tropic) HIV strain, predominantly utilizes the CXCR4 coreceptor for viral entry and
can infect both naive and memory T cell populations, being predominantly found in the latter
[31, 32]. Moreover, there is the possibility for HIV to acquire dual-tropism, termed R5X4,
in which case HIV can use both coreceptors. It is important to know that, while these trends
describe the majority of tropism behaviour, they certainly should not be considered concrete
biological rules as these trends contain at least a few exceptions[31, 33].
The R5-tropic strain of HIV is the tropism associated with establishment of new infection
transmission, as supported by its presence in the essentially every transmitted-founder (T/F)
variant — the HIV strain that establishes infection in a new host [31, 32]. Research suggests
this strong filter for R5 tropism is caused by predominant coreceptor expression patterns in
the mucosal layers where HIV transmission often takes place [34–36]. While R5-tropic HIV-1
is predominant throughout early infection, X4-tropic variants arise in approximately 50% of
patients after roughly 5 years [34, 37]. Importantly, the X4 tropism of HIV is associated with
faster depletion of T cell populations and progression to AIDS, due to the wider range of T
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cells that susceptible to these viruses [32].
1.5 Mutation & Evolution
Evolution refers to changes in the frequencies of genetic variants (or alleles) within biologi-
cal populations over successive generations [38]. Mutations (genetic changes) are responsible
for creating genetic diversity within populations that is required in order for evolution to occur.
There are multiple different types of mutations which include, but are not limited to, nucleotide
substitutions, insertions and deletions (indels), or even recombination of entire genomes [38].
Recall that a genome encodes the functional proteins that constitute an organism and thus,
mutations can, but not always, have direct effects on an organism’s phenotype [38]. The inter-
actions between an organism’s phenotype and its surrounding environment affects its ability to
survive and reproduce in a process known as selection, which can further shape evolution and
will be discussed more later.
Viruses occupy a unique position on the tree of life, which has often been debated due to
their lack of autonomous metabolic function and dependence on hijacking cellular machinery
to replicate [39]. However, viruses still undergo many of the same core biological processes
found in all biological organisms, including a reproductive cycle involving the inheritance of
genetic material that can affect phenotype [39, 40]. In this regard, evolution occurs within
viruses in the same way it occurs within humans, animals, or any other organisms, and can be
measured as such [41].
HIV-1 belongs to the family of RNA retroviruses, which exhibit some of the highest evolu-
tionary rates of any biological entity [42]. The evolution of HIV-1 is so fast than it is detectable
not only between different individuals, but also within a single person over the course of their
HIV-1 infection [42, 43]. This remarkable evolution, which is central to this work, is facili-
tated by several factors. For one, HIV-1 has a very fast generation time — the time from a
virus leaving a cell until it produces a new virus in a new cell — which has been estimated at
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approximately 2.6 days [44]. Moreover, there are high counts, approximately 107, of infected
CD4+ cells within the body during infection, each of which is capable of producing roughly
103 new virions [45]. As mentioned previously, the highly error-prone reverse transcription
process introduces between 1.4 and 3.4 ×10−5 mutations/nucleotide/replication which, when
accounting for the 9.2 kb genome length of HIV-1, equates to roughly one new mutation per
replication [24–26, 46]. Together, the genetic instability of HIV-1 along with the remarkable
size and growth of its population enables the efficient generation of enormous diversity.
1.5.1 Nucleotide Substitutions and Evolutionary Models
Nucleotide substitutions are central to the study of evolution, as they are the specific mutation
on which commonly-used models of evolution are based [47]. In other words, most models
of evolution (also referred to as substitution models) depend on nucleotide substitutions in
order to estimate evolutionary relatedness [47, 48]. Specifically, these models operate under
the assumption that substitutions are a stochastic process and account for the probabilities of
each nucleotide changing to any other nucleotide in a genetic sequence over time [47, 48].
The number of parameters in these models can vary considerably, though at least one of these
parameters is typically an expected substitution rate. An example of one substitution model
(Felsenstein ‘81) is represented below.
Q =

∗ µπC µπG µπT
µπA ∗ µπG µπT
µπA µπC ∗ µπT
µπA µπC µπG ∗

The above rate matrix Q contains a single rate parameter µ that controls how frequently all
substitutions occur, which is multiplied by three different parameters describing the frequencies
of all four nucleotides (πA, πC, πG; not four parameters because πA +πC +πG +πT = 1). Diagonal
values (*) represent a quantity such that each row must sum to 0.
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Importantly, evolutionary models can be used to reconstruct the evolutionary history of a
population in a procedure known as phylogenetic inference, which is central to this work which
will be further discussed in a coming section. There are many different substitution models,
each utilizing a unique set of parameters and making different assumptions. Briefly, some of
the most prominent substitutions models, which are named by their authors, include the Jukes-
Cantor, Kimura, Felsenstein, Hasegawa–Kishono–Yano, and Tamura-Nei models [49–53]. For
instance, the Jukes-Cantor model, being among the earliest models, uses a single rate param-
eter, assumes equal substitution rates between nucleotides, and equal starting distributions of
all nucleotides [52]. Additional complexity was then added to the subsequent advancements
of these models, two of which — the Felsenstein and Tamura-Nei models — are used in this
work. The Felsenstein 81 (F81) model adds parameterization of nucleotide frequencies allow-
ing their starting distributions to differ, while still maintaining a single substitution rate param-
eter [49]. The Tamura-Nei 93 (TN93) not only parameterizes nucleotide frequencies, but also
incorporates three different rate parameters: one describing the rate of nucleotide transversions
(A/G ↔ C/T ) and one for each type of transition (A↔ G, C ↔ T ) [51]
Substitution rates are a fundamental parameter in the field of viral evolution as they reflect a
virus’ ability to adapt to an individual host or entire population (i.e. humans) [54]. By rapidly
acquiring genetic change, HIV-1 populations are remarkably resilient and versatile when in-
fecting humans, as they can quickly respond to different environmental pressures such as those
induced by the host-specific immune responses.
1.5.2 Selection
Selection, a concept originally proposed by Charles Darwin, refers to the interactions between
an organism’s phenotype and the surrounding environment that affect the organism’s surviv-
ability and reproductive success, and is a concept central to the study of evolution [55]. Positive
selection describes the process by which mutations conferring a fitness advantage increase in
frequency within a population and is indicative of evolution that promotes adaptation to the
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environment (adaptive evolution) [56]. On the contrary, negative or purifying selection refers
to the removal of mutations with relatively lower fitness from the next generation [57, 58].
Populations can also be subject to neutral selection in which case organism-environment in-
teractions have minimal effects on allele frequencies, meaning that fluctuations in variants are
primarily modulated by stochastic processes [59]. Evidently, selection is an important consid-
eration when studying viral mutations, as these forces can significantly modulate their preva-
lence within populations. For instance, selection can permit mutations to reach fixation: the
increase of a genetic variant’s prevalence to 100% in the population [59]. Selection is applica-
ble to all biological entities which contain a genome coding for its phenotypic traits and inherit
genetic information, which importantly includes viruses like HIV-1 [40].
Interestingly, both positive and purifying selection shape the evolution of HIV-1 within
hosts and have been detected in numerous regions throughout the HIV-1 genome, with some
conflicting findings in particular genes [57, 60, 61]. Although these trends are more complex
when analyzed at a smaller resolution, the gag and gp41 genes generally tend to undergo more
purifying selection, while nef and pol are often subject to more positive selection [57, 62, 63].
Importantly, HIV-1 gp120 undergoes both positive and purifying selection. The effects of puri-
fying selection are most prominent in the conserved regions of gp120, meaning that mutations
here are frequently detrimental and get filtered out of the population [42, 58]. Areas expe-
riencing positive selection, on the other hand, are primarily found in this protein’s variable
regions (V1, V2, V3) and also show strong colocalization with known antibody and CTL bind-
ing sites. It is widely accepted that mutations at these sites confer a notable advantage and
undergo corresponding positive selection because they enable gp120 to avoid recognition by
the host immune response [57, 60, 64, 65].
1.5.3 Phylogenetic Inference
The study of evolution frequently relies on phylogenetic inference: the inference of a popu-
lation’s evolutionary relationships [66]. Central to phylogenetic inference procedures is the
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reconstruction of a phylogenetic tree, which is a model that describes the evolutionary related-
ness between different biological entities [67]. Phylogenetic trees contain their own parameters
— the order of branching (topology) and the lengths of each branch — and depend on a sub-
stitution model to calculate their likelihood, i.e. the probability of observing the data given
the model parameters [67]. Generally, the process of tree reconstruction first involves fitting a
model of evolution (discussed previously) to the population’s genetic sequence data, and subse-
quently solving for the parameter values of this model that best fit the data [66]. This procedure,
which is central to this thesis work, can be accomplished using multiple different statistical in-
ference methods. For example, a common approach is estimation by maximum likelihood
(ML), which involves determination of the parameter values that maximize the model’s as-
sociated likelihood function. Application of phylogenetic inference to viruses can be quite
fascinating and remarkable because, as previously mentioned, the virus evolutionary rates far
surpass those of other organisms [68]. Thus, we are able to observe evolution in short time
intervals that, in another organism, may take thousands or millions of years to occur (Figure
1.1) [68].
1.5.4 Indels
Insertions and deletions (indels) are a unique mutational mechanism given that they add or
remove genetic information and alter the overall length of sequences, unlike nucleotide sub-
stitutions that only change sequence composition [69]. While nucleotide substitutions form
the basis of commonly-used evolutionary models, there is inherent difficulty and uncertainty
associated with reconstructing indels and utilizing their information in phylogenetic inference
due to the fact that indels cannot be directly observed like substitutions [70]. In other words,
there is no direct indication that sequence has been inserted or deleted and thus the locations of
indels can only be inferred [70]. As a result, the process of reconstructing indels in a sequence
alignment is somewhat arbitrary and can change with sequence alignment parameters, leading
to the exclusion of indels from many common phylogenetic methods [70–72]. Newer phylo-
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Figure 1.1: A phylogenetic tree generated using maximum likelihood methods that describes
an HIV-1 infection within a single host. The bar in the bottom right corner provides a scale of
tree branch length units: expected substitutions per site.
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genetics methods, while not yet widespread, have begun testing and using the incorporation
of indels and have seen increases in accuracy for doing so [69–71] Despite their absence from
phylogenetic inference methods, indels still play a significant role in virus evolution and have
been shown to confer unique phenotypic traits in multiple viruses, not just HIV-1. For exam-
ple, specific insertions in the gag and pol genes of HIV-1 have been shown to confer enhanced
infectivity and drug resistance to the virus, respectively [73–75].
1.5.5 Recombination
Recombination refers to the incorporation of genetic information from two or more different
sources into the same genetic sequence [76]. In HIV-1, recombination occurs very frequently
and plays a significant role in shaping the evolution of this virus [42]. The estimated recombi-
nation rate of HIV-1 is roughly 1.4 ×10−5 events per site per cycle, which is comparable to the
estimated rate of substitutions [42]. HIV-1 is predisposed to undergo recombination, based on
its structure and mechanisms of replication [11]. Foremost, recombination is facilitated by the
diploid nature of HIV-1, meaning that it contains two copies of its genome per viral particle
[76]. If a susceptible cell becomes infected with two different HIV-1 particles, it is possible for
two genetically-distinct HIV-1 genomes to get incorporated into a single HIV-1 particle [76].
Recombination may then occur when this HIV-1 particle enters a new cell and undergoes re-
verse transcription [76]. Additionally, reverse transcription of HIV-1 involves the dissociation
and transfer of RT between template strands, meaning that affinity between the RT enzyme and
the nucleotide sequence is relatively low [11]. It is plausible that RT could be transferred in-
correctly to a second proximal RNA molecule during this step, thereby creating a recombinant
RNA genome containing portions of both templates [11].
1.5.6 Diversity & Evolution Within Hosts
Recall that HIV-1 evolves so rapidly that substantial diversity and evolution is found not only
among different hosts, but within the HIV-1 population circulating in a single infected host too
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[77]. This provides two different scales at which HIV-1 diversity and evolution can be studied.
As previously discussed, evolution on a within-host scale is driven by the virus’ large popu-
lation sizes, efficient replication, and rapid accumulation of mutations via substitutions, indels,
and recombination [24, 25, 42, 44]. Interestingly, these factors facilitate a highly heteroge-
neous HIV-1 population structure within hosts, suggested to be comprised of numerous smaller
subpopulations that each originate from a different virus variant and thus have a distinct ge-
netic profile [78–80]. This population structure, described as a metapopulation or quasispecies,
further enables HIV-1 to rapidly adapt to the host environment [81] and is believed to be par-
tially facilitated by its localization to multiple different bodily compartments, which include
the blood, lymph nodes, genital tract, and brain [78, 80, 82].
This complex population structure is further shaped by evolutionary forces, which include,
but are not limited to, positive and negative (purifying) selection. For one, HIV-1 primarily un-
dergoes adaptive evolution within hosts to evade the cell- and antibody-mediate host immune
responses, which involves the positive selection of advantageous mutations that confer immune
escape [42, 60, 61, 65]. This adaptive evolution is so prevalent that HIV-1 is further suggested
to be “short-sighted” by some, in that increases in viral fitness are almost always favoured even
to the extent of sacrificing transmission fitness [83]. These advantageous mutations get succes-
sively fixed in the population over time, causing the gradual and consistent divergence away
from the founding variant and toward a well-adapted one, such as those capable of evading
the immune system [54, 59]. Adaptive evolution accounts for the highly directional nature of
within host evolution, as demonstrated by the asymmetrical shape of the phylogenetic tree in
Figure 1.1. Importantly, while positive selection predominates, there is also purifying selection
acting within hosts which filters out detrimental mutations that compromise virus functionality
[58]. Therefore, both positive and purifying selection exert modulating effects on genetic vari-
ant frequencies and importantly, influence which mutations will reach fixation in the population
[59].
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1.5.7 Diversity & Evolution Among Hosts
HIV-1 exhibits considerable genetic differences between different human hosts, which are even
more pronounced between human populations in different geographical regions. After initial
transmission to humans in Central Africa, HIV-1 group M spread globally and formed further
distinct clades: populations containing all the descendants that originate from a single ancestor
[3]. Based on these distinct clades, HIV-1 group M was stratified into nine major subtypes (A-
D, F-J) which differ in their amino acid sequences by 10% to 35% depending on the examined
gene [3]. Currently, the group M subtypes are localized to different geographical regions due to
historical founder effects: the reduction and change of genetic diversity caused by few individ-
uals from a large population entering a novel environment [3]. For example, HIV-1 subtype B
is predominantly found in North America, while subtype C is found heavily in Africa and East-
ern Asia [3]. The clades of group M are an important factor to consider when studying HIV-1
given they are suggested to differ in their mother-to-child transmission efficiency [84], tropism
phenotype [85], genital mucosa injury [86], Nef-mediated suppression of the CTL response
[87], and rate of disease progression [88].
The evolutionary processes that shape among host diversity are primarily associated with
transmission. The transmission of HIV-1 to a new host is associated with strong population
bottleneck effects, which refers to the drastic changes to genetic diversity caused by a reduc-
tion in population size [78]. In fact, it has been found that approximately 80% of new HIV
subtype B and C infections originate from only a single T/F virus, despite there often being a
large and diverse HIV population within the transmitting host [89–91]. The genotypes of the
one or few founding viruses will therefore, dictate those of the whole population after sufficient
viral expansion, allowing the new viral population to become considerably different from its
original. Additionally, transmitted HIV-1 variants have been found to be more similar to the
virus that originally established its infection than the current HIV-1 population. [92]. This ap-
parent reversion of genetic diversity has been described in literature as the “store and retrieve”
hypothesis [92]. This proposed trend in HIV-1 evolution accounts for the lower evolutionary
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rates observed among hosts than within hosts and the apparent loss of genetic changes in new
founding viruses relative to their populations of origin [93, 94]. Mechanistically, this may be
associated with the strong transmission bottleneck of HIV-1 that appears to select for a partic-
ular phenotype, i.e. the R5 tropism phenotype present in 100% of T/F viruses [32, 95].
1.6 HIV-1 Pathogenesis
Pathogenesis refers to the biological mechanisms responsible for inducing disease [96]. HIV-
1 induces disease in humans by infecting and destroying CD4+ immune cell populations, the
most important of which are those of T helper cells [97]. The pathogenesis of HIV-1 involves
multiple different stages of infection, each with unique and important concepts [97].
1.6.1 Transmission
Transmission of HIV-1 to a new host involves exposure of the virus either to bodily mucosal
layers or the subcutaneous tissue [98]. The most common routes of HIV transmission include
homo- and heterosexual contact, mother-to-child exposure, and subcutaneous injection [98].
Each route of transmission has a different level of associated risk based on the permissiveness
of the tissue and the common medium by which virus is transferred [98].
1.6.2 Immune Response to HIV-1
Shortly after the establishment of HIV-1 infection, a substantial cell-mediated immune re-
sponse is mounted against HIV-1, involving activation of numerous CD8+ cytotoxic T lym-
phocytes (CTLs) [99]. CTLs play a critical role in fighting viral infections due to their func-
tional focus on eliminating intracellular pathogens. To detect infected cells, CTLs rely on the
presentation of viral peptides on human leukocyte antigen (HLA) class 1 molecules, and upon
doing so, can then lyse these cells using stored perforin and granzyme proteins [99]. The CTL
response can target a wide range of viral peptides spanning many of the HIV-1 functional pro-
1.6. HIV-1 Pathogenesis 17
teins, including those encoded by gag, pol, and env [100]. The efficiency of the CTL response
is further dependent on different HLA class 1 molecules, which display substantial variation
particularly between ethnicities [101]. People can therefore present with considerable differ-
ences in response to HIV-1 infection based on their type of HLA class 1 molecule [101]. While
CTL-induced cell death is the primary antiviral response, CTLs also release cytokines that
suppress HIV-1 replication and entry in nearby cells [99].
A few weeks after the start of infection and the initiation of the CTL response, the humoral
immune system — the portion of the immune system responsible for antibody production —
begins mounting a response against HIV-1, involving the production of both neutralizing and
non-neutralizing antibodies [102]. Briefly, neutralizing antibodies suppress infection by bind-
ing to and incapacitating free-floating virus within circulation, while non-neutralizing ones ac-
tivate other components of the antiviral immune response — including the protein complement
system, phagocytes, and natural killer cells — to destroy virus and infected cells in an indirect
manner [102]. To bind to the virus, neutralizing antibodies can specifically target the gp120,
gp41, matrix (p17), and capsid (p24) proteins of HIV-1, though the majority of responses are
elicited against gp120 due to its extracellular position [102, 103]. The majority of subjects
infected with HIV-1 elicit a neutralizing antibody response against gp120, which contributes
to suppression of HIV-1 viral load [103].
1.6.3 Immune Escape
The cell- and antibody-mediated immune response both contribute to the initial suppression
of circulating HIV-1 populations, or viral load [60]. In the majority of cases however, neither
response is able to effectively clear HIV-1 infection from the body, resulting in the progression
to AIDS for which there is no cure. The inability to clear HIV-1 is primarily due to the virus
population’s high heterogeneity and rapid evolution, which enables the generation of variants
that evade this response in a process referred to as immune escape [60, 104]. Recall that both
the CTL and humoral immune responses bind to specific viral protein structures in order to
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detect and neutralize virally-infected cells or the virus itself [60]. Of the numerous HIV-1
variants in circulation, those viruses containing the targeted protein variant will be less likely
to propagate into further generations. On the other hand however, virus variants that acquire
mutations at the targeted protein site which prevent recognition by the immune responses will
undergo positive selection, as they receive a strong evolutionary advantage and experience less
competition for susceptible cells [99, 105]. Under positive selection, these immune escape
variants will increase in frequency, gradually making more of the HIV-1 population resistant
to the immune response [106]. It is important to note, however, that this process is a constant
battle between virus and immune response as opposed to a single pathway described above.
1.6.4 Phases of Infection
There are three major phases that describe the course of HIV-1 infection: a short acute phase,
a long asymptomatic phase, and the final immune compromised phase (AIDS) [107]. During
the acute phase of infection which typically lasts between 2 and 10 weeks, HIV-1 rapidly
replicates within susceptible CD4+ cells, resulting in a large viral load and importantly, a sharp
decline of helper T cells [107]. The affected individual will present with symptoms of an
acute infection, which commonly include fever, headache and pharyngitis [107]. Later in this
phase, an HIV-specific CTL immune response reaches full capacity, which depletes the viral
population considerably and permits the re-population of CD4+ helper T cells [107]. At the
end of the acute phase, HIV-1 is typically under sufficient control at low to moderate levels
and will establish the set point viral load: the stabilized level of circulating virus that persists
for the next asymptomatic phase of infection [108, 109]. The set point viral load can differ
dramatically between infected hosts and importantly predicts the rate of disease progression
over the remaining course of infection [108, 109].
Next is the asymptomatic phase of HIV-1 infection which typically lasts between 7 and
10 years but demonstrates large variation in duration between patients [107, 110]. During
this period, the patient presents without symptoms of infection as the virus is suppressed to
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relatively moderate or low levels in the body [107]. However, the virus continues to infect
susceptible cells and evolve in this suppressed state [111]. Importantly, it is during this stage
that the HIV-1 population predominantly undergoes adaptive evolution in response to host
immune responses, thereby giving rise to immune escape variants under positive selection
[59, 111]. The continual generation of new escape variants gradually increases the viral load
during the asymptomatic phase until this resistant population becomes large enough to fully
overwhelm the immune system [59, 111].
The final stage, AIDS, occurs when the virus begins to overwhelm the immune response,
typically due to high prevalence of escape mutants in the viral population and the sufficient
depletion of helper T lymphocytes [112]. Although all CD4+ cell types play an important
role in immune responses, AIDS is specifically defined by the sufficient depletion of CD4+
helper T lymphocytes specifically [112, 113]. Helper T cells are essential to the activation and
specificity of both the antibody- and cell-mediated responses of the adaptive immune system
[114]. In AIDS, helper T cell populations are depleted, compromising the entire adaptive
immune system and leading to an inability to combat even low virulence pathogens [112–114].
1.7 gp120
My research focuses specifically on the gp120 surface glycoprotein of HIV-1. Recall that this
protein mediates initial attachment of HIV-1 to susceptible immune cells by binding the CD4
receptor and a second chemokine coreceptor [115]. The env gene of HIV-1 that codes for gp120
and gp41 exhibits higher rates of evolution than other genes such as gag and pol [43].
1.7.1 Glycosylation
The gp120 glycoprotein is one of the most heavily glycosylated proteins known in nature, as
approximately 50% of its molecular weight is associated with its numerous glycan sugar com-
plexes [116]. The abundant glycosylation on gp120 is facilitated by this protein’s numerous
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potential N-linked glycosylation sites (PNGS): amino acid sequences that encode the post-
translational attachment of a glycan to asparagine (N) residues. This dense, protective layer
of glycan sugars is referred to as the “glycan shield” and protects the susceptible conserved
regions of this protein often targeted by neutralizing antibodies [117]. Interestingly, the gp120
glycans themselves can be the target of neutralizing antibodies generated by the host immune
response as well [118]. The broadly neutralizing antibodies 2G12 and PGT128, for example,
have been shown to bind to specific glycans on gp120 [118, 119]. Therefore, N-linked glycans
on gp120 are susceptible to selective pressures due to their interactions with the immune re-
sponse [118]. Importantly, the glycan shield can respond to these pressures because it is highly
dynamic in nature. The frequent mutations in gp120 can create or remove PNGSs in its protein
sequence and thus alter the protein’s overall glycan sugar patterns [117]. In fact, increases in
gp120 glycan counts over the course of infection, particularly in the variable loops, has been
reported by both Derdeyn et al. [120] and Sagar et al. [121], supporting the hypothesis that
gp120 “raises” its glycan shield to evade immune responses.
1.7.2 Variable Loops
Another important feature of the gp120 gene is its distinct genetic segmentation into five con-
served (C1-C5) and five variable regions (V1-V5), which has been well documented since
being reported in 1986 by Starcich et al. [122]. In the physical protein structure, the conserved
regions of this protein are primarily hidden in its interior, while the variable regions form five
disordered loop structures on the protein’s exterior anchored by disuphide bonds at their base.
The variable loops are located on the exterior on gp120 and therefore, experience notable selec-
tive pressures from neutralizing antibody responses [117]. This selection facilitates the rapid
accumulation of sequence mutations in the variable loops, which include both substitutions
and indels [18]. The substitution rates in these regions, for example, are even higher than that
of env as a whole [18, 123]. Mutations can generate substantial structural variability in these
loops by not only changing the compositions and lengths of the loops, but also by changing
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variable loop glycosylation patterns [18]. The high variability observed in the variable loops
makes them a difficult target and thus offers protection for some of the more conserved regions
of gp120, including the CD4 binding site for example [18].
1.7.3 Immune Escape
While gp120 is targeted by neutralizing antibody responses, these responses remain unable
to effectively bind gp120 due to its dense glycan shield and rapidly mutating variable loops
[18, 117, 117, 121]. The elusive nature of gp120 is driven by mutations in the variable loops
that frequently generate immune escape variants by rapidly changing the lengths, compositions,
and glycan content of these loop structures [18, 117]. As discussed previously, gp120 escape
variants experience a significant evolutionary advantage and increase in prevalence due to the
considerable positive selection applied by the neutralizing antibody response [18, 121, 124].
Escape from these antibodies allows HIV-1 to remain functional within circulation and con-
tinue to infect new immune cells [118].
The gp120 variable loops have been shown to accumulate an abundance of indel events
[18]. Indels specifically can induce many of the aforementioned changes to the variable loops
(i.e. lengths, glycosylation patterns, amino acid compositions) that have been reported to gen-
erate gp120 immune escape variants [18, 105, 117, 125]. These findings implicate variable
loop indels in the onset of gp120 immune escape and provide the core rationale for investigat-
ing these particular mutations in this work [18].
1.7.4 Variable Loop Indel Rates
Rates of sequence evolution are important parameters to the study of HIV-1 for a few rea-
sons. For instance, substitution rates are generally suggested to influence a biological entity’s
capacity to adapt to dynamic environmental pressures and in the case of viral infections, are
suggested to correlate with the rate of disease progression [26, 54]. Rates of sequence evolution
also allow mutations to be used as a source of phylogenetic information in inference methods
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when incorporated into a suitable model, i.e. like the use of nucleotide substitutions in current
phylogenetic methods [49, 51].
While nucleotide substitution rates have been extensively studied in HIV-1 [43, 123, 126],
there are no studies, to our knowledge, that have investigated and estimated rates of indel evo-
lution in HIV-1 occurring in human hosts. It is important to note that Mansky and Temin [24]
estimated the rate of indel accumulation in the HIV-1 genome using in vitro methods; however,
this study reports an indel mutation rate, not a rate of indel evolution that we are investigating
in this work. A mutation rate measures how frequently cellular machinery generates mutations
during a single viral replication cycle within a cell [43]. On the other hand, evolutionary rates
measure the relative accumulation of mutations among population lineages as they diverge over
time and importantly, are driven by forces such as natural selection and genetic drift [43]. In
other words, mutation rates are describing the creation of raw genetic diversity, while evolu-
tionary rates are describing how mutations are shaped within a population as it interacts with
its environment.
Without rates of indel evolution or an effective model describing these processes, indels re-
main an unused source of phylogenetic information in the study of HIV-1. Estimation of HIV-1
indel evolution rates would therefore, mark an important first step towards their effective incor-
poration into phylogenetic inference methods. Moreover, the contributions of indels towards
HIV-1 sequence evolution and adaptation in specific genetic regions (i.e. the gp120 variable
loops) also remain unknown without estimates of their rates. No studies have attempted to
estimate indel rates specifically within the gp120 gene or the variable regions where indels
are biologically significant in their contributions toward immune escape. It is therefore clear
that indel rates, particularly in HIV-1 gp120, are an important topic needing to be addressed in
modern HIV-1 research through the use of patient-derived genetic sequence data.
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In this work, I first address this knowledge gap by providing the first estimates of gp120 vari-
able loop indel rates on both a within-host and among-host scale using phylogenetic methods
and compare these estimates to each other. I further examine lengths and compositions of re-
covered indels, and importantly, how frequently indels induce changes to PNGSs that form the
glycan shield of gp120. Finally, I investigate whether the characteristics of observed variable
loop indels can be effectively described using an empirical model, with aims of understanding
the parameters governing indel generation.
1.9 Hypothesis
I foremost hypothesize that indel rates can be determined in the variable loops of gp120 using
dated phylogenetic analyses on both among-host and within-host scales. On an among-host
scale, I predict that indel rates will differ significantly among the group M subtypes, showing
concordance with subtype differences in phenotype. I further expect to observe significantly
higher indel rates within hosts than among hosts, due to the strong purifying selection acting
on the level of transmission events in HIV-1. I also predict finding more indels that induce
frameshift mutations within hosts than among hosts, on the same basis that there is less purify-
ing selection acting within hosts than among hosts. Finally, I postulate that the characteristics
of gp120 indels can be effectively described using an empirical model of replication slippage.
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Extremely high mutation rate of HIV-1 in vivo. PLoS Biol, 13(9):e1002251, 2015.
[27] Bodo Linz, Helen M Windsor, John J McGraw, Lori M Hansen, John P Gajewski, Lynn P
Tomsho, Caylie M Hake, Jay V Solnick, Stephan C Schuster, and Barry J Marshall. A
mutation burst during the acute phase of helicobacter pylori infection in humans and
rhesus macaques. Nature communications, 5(1):1–8, 2014.
[28] Serguei Popov, Michael Rexach, Gabriele Zybarth, Norbert Reiling, May-Ann Lee, Lee
Ratner, Cynthia M Lane, Mary Shannon Moore, Günter Blobel, and Michael Bukrinsky.
Viral protein R regulates nuclear import of the HIV-1 pre-integration complex. The
EMBO journal, 17(4):909–917, 1998.
[29] Milena S Espı́ndola, Luana S Soares, Leonardo J Galvao-Lima, Fabiana A Zambuzi,
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Chapter 2
Indel Evolution Among Hosts
2.1 Background
My work included in this chapter is reproduced from the published journal article Palmer and
Poon [1]. I included this article as a chapter because it contains work conducted during the
first 6 months of my masters program and served as the foundation for the primary component
of my thesis project in Chapter 3. To reiterate, I produced Table 2.1, Figures 2.4 and 2.5, and
Supplementary Figures A1 and A2 during the first 6 months of my masters program, while re-
maining work was conducted during my BMSc program. Here, I will provide a short overview
of crucial concepts and contextual information needed to understand this study.
2.1.1 Context
Foremost, substitution rates have been previously studied in gp120 and the variable regions
[2–5], but indel rates have not. It is also widely accepted that indels rapidly accumulate in the
gp120 variable loops, particularly V1, V2, V4, and V5, and are suggested to play a role in
immune escape in these regions [6–10].
Importantly, this study uses HIV-1 genetic sequence data sampled among hosts in the hu-
man population, meaning that a single HIV-1 sequence was selected to represent each patient.
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These sequences are often generated using Sanger sequencing methods and therefore, represent
the consensus of a patient’s highly-diverse HIV-1 population [11, 12]. These Sanger sequences
only tend to contain those mutations that have come sufficiently close to reaching fixation
(i.e. 100% prevalence) in the population and typically does not register lower frequency vari-
ants [11–13]. The process of reaching fixation typically involves enduring extensive purifying
selection over countless viral generations, thereby making the sampled consensus sequence
a highly refined and filtered representation of the HIV-1 population [14]. Given our use of
among-host sequence data, this study is specifically measuring the rates at which indels are
being fixed in the gp120 variable loops at the population level. It is not measuring the rates
of indel accumulation in the virus population within individual hosts, which will be covered in
Chapter 3.
Use of among host data also facilitated the collection of sequences worldwide that included
several HIV-1 group M subtypes. Recall from Chapter 1 that the HIV-1 group M subtypes
exhibit considerable genetic differences which can reach as high as 35% in env [15]. Given the
substantial differences among HIV-1 group M, we wanted to further test the hypothesis that
the HIV-1 subtypes exhibit difference in variable loop indel rates. The term “clade”, which
describes populations containing all the descendants that originate from a single ancestor, is
used throughout this study to accurately describe both subtypes and CRFs together.
2.1.2 Pairwise Alignment
To extract the variable regions, I used a reference sequence describing HIV-1 subtype B called
HXB2 (Genbank Acession: K03455), which has been annotated at every nucleotide position
for relevant genetic regions, protein structures, and various other characteristics [16]. The
process of aligning each gp120 sequence with this reference sequence adds necessary gaps to
both sequences to bring their matching features into the same positions, including the variable
regions. Therefore, the positions of the variable regions in the HXB2 reference sequence allow
me to locate the corresponding variable region locations in the patient-derived sequence.
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2.1.3 Phylogenetic Inference
In this study, I used phylogenetic inference methods to estimate the rates of evolution, estimate
the time to the most recent common ancestor (tMRCA), and reconstruct trees on a per-subtype
basis. I will briefly outline some key concepts involved in this process.
First, phylogenetic trees are initially generated in an unrooted format, which only describe
the relatedness of different lineages — individual lines of descent from ancestors — and do not
describe the direction of evolution from a common ancestor [17]. Rooting a phylogenetic tree
involves inferring the root of the tree — the theoretical common ancestor of all sampled tree
tips — which, in turn, also enables reconstruction of evolutionary history relating tree lineages
originating from this point [17]. The methods I used to root my phylogenetic trees in this study
rely on the assumption of a molecular clock in the data: a hypothesis that biological sequences
(i.e. DNA or amino acids) evolve or accumulate mutations at a constant rate over time which
enables the reconstruction and analysis of evolutionary history [18]. One of the processes I
used is called root-to-tip regression, which is a linear model fit between the sampling dates and
genetic differences of tip sequences relative to the root [19]. When assuming that only a single
underlying substitution rate exists, this hypothesis is more specifically referred to as the strict
molecular clock [19]. The goodness of fit of the root-to-tip regression indicates how well the
tree adheres to the strict molecular clock hypothesis, and therefore can be used to search for
the most appropriate root position [19].
The second method I used to root phylogenetic trees in this study is called least-squares-
dating (LSD) [20]. This method utilizes a relaxed molecular clock, which allows the substitu-
tion rate to change between branches within a phylogenetic tree based on an underlying rate
distribution [20]. It applies a minimization algorithm to the square errors of branch lengths to
estimate the substitution rate and further approximates an underlying distribution from which
the rate of each tree branch is drawn [20]. Relaxed molecular clock approaches are preferred
for rapidly evolving pathogens due to the considerable heterogeneity in evolution between dif-
ferent lineages [21].
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I then use the root-to-tip strict clock method and the LSD relaxed clock to estimate the
tMRCA of each HIV-1 group M clade. This is done by determining the mean substitution rate
and extrapolating back in time to estimate the date of the tree root, or MRCA.
2.1.4 Indel Rate Estimation
In our phylogenetic trees, we compared the lengths of variable loop sequences at every pair
of cherries: pairs of sequences related by a common ancestor with no intervening nodes in
between. We estimated indel rates in our phylogenetic trees by fitting a customized statistical
model to our data and solving for the parameter values that best fit the data using maximum
likelihood methods. Indels were detected as true/false outcomes, and therefore warranted a
unique approach to determine the underlying indel rate. The model used in this study incorpo-
rates a true/false outcome into a Poisson likelihood function, which produces the probability
of seeing count data given a particular rate and length of time. In the equation below, Yi either
takes the value of 0 or 1 based on whether the variable loop lengths in cherries were the same
or different, respectively. We used the presence of length differences to detect indel events over
short time periods in cherries. The time data of the associated cherry sequence pair is provided
as ti, and used to solve for the single underlying indel rate λ in each subtype’s phylogenetic
tree.
The indel rate was estimated from these data by fitting the following model using maximum
likelihood, where the Bernoulli likelihood for the i-th cherry is:
L(Yi|λ, ti) = (1 − Yi)e−λti + Yi(1 − e−λti)
where Yi = 1 if the sequence lengths differ (implying one or more indels), and is 0 otherwise;
ti is the total branch length, λ is the overall indel rate, and e−λti is the Poisson probability of no
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indels in the cherry. The total log-likelihood across cherries is thus:
log L =
∑
i
log L(Yi|λ, ti)
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Phylogenetic measures of indel rate variation among
the HIV-1 group M subtypes 1
2.2 Introduction
Human immunodeficiency virus type 1 (HIV-1) is a rapidly evolving retrovirus with enormous
genetic diversity that is divided into four groups (M, N, O and P). The global HIV-1 pandemic
that affects approximately 37 million people as of 2017 [22] is largely caused by group M,
which is further partitioned into nine subtypes (A-D, F-H, J, K) that can differ by roughly 30%
of their genome sequence and have distinct geographic distributions due to historical founder
effects [15, 23]. In addition, there are a large number of circulating recombinant forms (CRFs)
that are the result of recombination among two or more HIV-1 subtypes that have subsequently
become established in particular regions at high prevalence. There is accumulating empirical
evidence of significant variation among specific HIV-1 subtypes with respect to pathogenesis,
e.g., rates of disease progression, and the evolution of drug resistance, which implies that the
HIV-1 subtypes and CRFs are clinically significant [24–27].
In the host cell-derived lipid membrane of every HIV-1 particle, there are numerous virus-
encoded envelope glycoprotein complexes composed of three gp41 transmembrane units and
three gp120 surface units [28]. The HIV-1 gp120 glycoprotein is a potent surface-exposed
antigen that plays a significant role in the recognition and binding of target cell receptors [29].
One reason for the difficulty in immunologically targeting this glycoprotein is the abundance
of N-linked glycoslyation sites: sequence motifs that encode the post-translational linkage of
glycan groups to asparagine residues [30]. In addition, the HIV-1 gene encoding gp120 has a
particularly high rate of evolution, especially within the five hypervariable regions that encode
surface-exposed, disordered loop structures. These five variable regions (numbered V1-V5)
1Contents in this chapter have been reproduced from: Palmer J, Poon AFY. Virus Evol. 2019 Jul
21;5(2):vez022. doi: 10.1093/ve/vez022. The study was published under the terms of the Creative Commons
Attribution Non-Commercial License, which permits non-commercial re-use, distribution, and reproduction in
any medium, provided the original work is properly cited.
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can tolerate substantially higher amino acid substitution rates than the rest of the HIV-1 genome
[3]. Both the extensive glycosylation and rapid substitution rates in HIV-1 gp120 facilitate the
escape of the virus from neutralizing antibodies [8].
There are multiple mechanisms by which mutations arise within the HIV-1 genome includ-
ing nucleotide substitutions, insertions, and deletions [31]. While substitution rates have been
extensively characterized in HIV-1 and specifically in the env gene [32, 33], less attention has
been given to sequence insertions and deletions (indels). The few studies that examine indels in
the HIV-1 genome have focused on the location, behaviour, and clinical significance of specifi-
cally recurring indels, such as indels in HIV-1 pol associated with drug resistance and indels in
gag and vif associated with disease progression and infectivity [34–36]. Only a small number
of comparative studies have examined indel rates in the HIV-1 env gene encoding gp120 and
gp41. Wood et al. [8], for one, found that indels preferentially accumulate in the variable loops
of gp120 compared to the remainder of this sequence, while other studies have suggested that
variable loop indels correspond with HIV-1 transmission and modulate coreceptor switching
[37, 38].
Despite the significant impact of indels within HIV-1 gp120 on virus transmission and
adaptation, the overall rates of indel evolution in gp120 have not yet been measured through a
comparative analysis. Furthermore, as previous studies on indels in HIV-1 have tended to focus
on defined study populations, we have not found any study that has examined indel rates in a
large database covering multiple HIV-1 subtypes and geographical regions. Here we present
results from a dated-tip phylogenetic analysis of HIV-1 env sequences from a public database.
By comparing sequences from different hosts, our analysis focuses on fixed indel differences
that are tolerated by the virus; for example, this analysis implicitly excludes indels that induce
frameshifts in env. Our novel phylogenetic method specifically analyzes ‘cherries’ [39] — pairs
of sequences directly descended from a common ancestor with no intervening ancestral nodes
— in time-scaled phylogenies to estimate the rates of indel evolution in the gp120 variable
loops of seven HIV-1 group M subtypes and CRFs (herein referred to collectively as clades).
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We focused on cherries to reduce the exposure of indels to purifying selection, and also the
probability of multiple indel events occurring in the same variable region, as the divergence
time in a cherry tends to be shorter on average than a random selection of two tips. Using this
method, we evaluate the hypothesis that the mean rates of indels significantly vary among the
gp120 variable loops and group M clades. Further, we examine the nucleotide composition of
indels to assess how this characteristic might be shaped by the virus genome, and quantify the
impact of indels on N-linked glycosylation sites in HIV-1 gp120.
2.3 Methods
2.3.1 Data processing
We queried the Los Alamos National Laboratory (LANL) HIV Sequence Database (http://
www.hiv.lanl.gov/) for all sequence records covering HIV-1 env gp120, limiting the records to
one sequence per patient. The 26,359 matching sequences were downloaded with predicted
subtype, collection year and GenBank accession number. We parsed the resulting FASTA
file and removed sequences that lacked subtype or collection year fields, or were shorter than
1400 nt (roughly 90% of full-length HIV-1 gp120), yielding a final data set of 6605 sequences.
To extract the interval encoding gp120 from each sequence and partition the result into the
variable and conserved regions, we performed pairwise alignments using an implementation
of the Altschul-Erickson [40] modification of the Gotoh algorithm in Python (http://github.
com/ArtPoon/gotoh2). Each nucleotide sequence was aligned against the HXB2 (Genbank
accession number K03455) gp120 reference sequence with match/mismatch scores of +5/−4,
gap open/extension penalties of 30 and 10, respectively, and no terminal gap penalty. The
aligned query sequence was cut at the boundaries of the aligned HXB2 reference gene to extract
the patient-derived subsequence homologous to gp120. Next, we removed any gaps in this
result and then aligned the amino acid translation to the gp120 protein reference sequence
using an empirical HIV amino acid scoring matrix (25% divergence [41]) with the same gap
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penalties, except that terminal gaps were penalized at this stage. Finally, we used the aligned
query to insert gap character triplets into the preceding nucleotide sequence as ‘in-frame’ codon
deletions.
Using the HXB2 reference annotations, we extracted the five variable (V1-V5) and five
conserved (C1-C5) regions of gp120. The conserved region sequences were concatenated and
exported to separate files for phylogenetic reconstruction. We subsequently determined that
our method was not reliably extracting the V5 regions, based on the overabundance of multiple
gap characters at the 5’ end of many outputs. To avoid further problems downstream, we imple-
mented a modified extraction method specific to V5. We first extracted nine extra nucleotides
beyond the 5’ boundary of the V5 reference to provide conserved sequence coverage outside
this hypervariable region. The extended V5 sequence was then translated and aligned to a V5
amino acid reference sequence of matching length as above. Lastly, we used the first non-gap
character (a matched amino acid) immediately following the first three conserved residues in
the amino acid alignment as the adjusted V5 start position, thereby omitting any gap characters
that preceded this first residue.
2.3.2 Phylogenetic analysis
We used the program MAFFT (version 7.271) with the default settings [42] to generate a
multiple sequence alignment (MSA) from the concatenated sequences of conserved regions
for each subtype. On manual inspection of the resulting MSAs, we found some alignment
columns comprised mostly of gaps caused by rare insertions, so we removed all columns with
gap characters in more than 95% of sequences. Next, we reconstructed phylogenies for each
subtype-specific MSA by approximate maximum likelihood using FastTree2 (version 2.1.8)
compiled with double precision [43]. The resulting trees were manually screened for unusu-
ally long terminal branches indicative of problematic sequences, which we removed from the
corresponding MSA before reconstructing a revised tree.
Effective estimation of indel rates required that all phylogenetic trees be scaled in time.
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To rescale the maximum likelihood trees, sequence accession numbers were used to query the
GenBank database for more precise collection dates containing month and day fields; otherwise
we retained the collection years from the LANL database. The R package ape was then used
to change each tree into a strictly bifurcating structure and to root the tree using root-to-tip
regression [19] based on the associated tip dates. We evaluated the correlation between the
time since the inferred root date (x-intercept) and the total branch length (in expected numbers
of substitutions) to determine if the data were consistent with a molecular clock [44].
Using the same dates, we employed the least-squares dating (LSD) program [20] to adjust
node heights and rescale the tree in time under a relaxed molecular clock model. Dates lacking
either month or day fields were specified as bounded intervals. The time-scaled tree outputs
from LSD were imported into R to extract the ‘cherries’: pairs of sequences directly descended
from a common ancestor with no intervening ancestral nodes. Focusing on sequences in cher-
ries provides phylogenetically independent observations and minimizes the divergence times,
thereby reducing the chance of encountering multiple indel events as well as the effect of pu-
rifying selection on indels. Cherries with time-scaled branch lengths totaling zero years were
removed from our analysis as they did not provide meaningful indel observations and caused
problems for rate estimation.
2.3.3 Indel rate estimation
To estimate the rate of indels in the variable loops, homologous variable regions from each
pair of sequences in a cherry were compared for length differences. The presence of a length
difference was reported as a binomial outcome implying that an indel event had occurred along
these branches; this approach does not account for the possibility of multiple indels causing
reversion to the same sequence lengths. Additionally, the total branch lengths comprising the
cherry was employed as an estimate of divergence time in years (Supplementary Figure A2).
The indel rate was estimated from these data by fitting the following model using maximum
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likelihood, where the Bernoulli likelihood for the i-th cherry is:
L(Yi|λ, ti) = (1 − Yi)e−λti + Yi(1 − e−λti)
where Yi = 1 if the sequence lengths differ (implying one or more indels), and is 0 otherwise;
ti is the total branch length, λ is the overall indel rate, and e−λti is the Poisson probability of no
indels in the cherry. The total log-likelihood across cherries is thus:
log L =
∑
i
log L(Yi|λ, ti)
We used the Brent minimization method implemented in the R package ‘bbmle’ to obtain a
maximum likelihood estimate of λ for each clade and variable loop combination. A general-
ized linear model (GLM) with a logit link function was also applied to these data to evaluate
statistical associations of the inferred distribution of indels on clades and variable loops; the
model incorporated a divergence time term as a rudimentary adjustment for variation in ‘sam-
pling effort’.
2.3.4 Analysis of indels
For every combination of five variable loops and seven clades, we categorized the inferred
lengths of indels into three discrete classes: single-codon (3 nt), double-codon (6 nt), and long
(9+ nt). Pearson χ2 residuals were calculated on these distributions to determine if, and in what
direction, these observed proportions significantly deviated from their expected values. To fur-
ther analyze the composition of indels, we generated pairwise alignments for each cherry with
discordant sequence lengths to identify and extract indels. From these pairwise alignments, we
calculated the proportions of adenine, thymine, guanine, and cytosine (A,C,G,T) nucleotides in
the indel and non-indel regions of the gp120 variable loops. In addition, we recorded the posi-
tions and numbers of PNGSs in the five gp120 variable loops by scanning the unaligned amino
acid sequences with the regular expression ‘N[ˆP][ST][ˆP]’, where ‘ˆP’ maps to any symbol ex-
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cept P (proline). We then used these data to investigate how commonly indels tended to change
PNGSs in the variable loops. By combining PNGS and indel location data, we searched for
instances where an indel overlapped with a PNGS in one of the two sequences of a cherry, in-
dicating either the deletion of a PNGS or the insertion of a sequence containing one. To avoid
recording instances of partial indel overlap that leave the PNGS intact, we verified the PNGS
was disrupted by scanning it again with a regular expression.
2.4 Results
We collected HIV-1 sequences covering gp120 from the Los Alamos National Laboratory
(LANL) HIV Sequence Database (http://www.hiv.lanl.gov/) and filtered these data (as de-
scribed in Methods) to obtain a final data set of 6,605 sequences. To estimate the rates of
indel evolution for different HIV-1 subtypes and circulating recombinant forms (CRFs) in this
data set, we reconstructed phylogenies for each of the seven group M clades using maximum
likelihood, and then rooted and rescaled each tree based on the sample collection dates under
a molecular clock model. Initially we employed a strict clock model in root-to-tip regressions
(Figure 2.1) to assess whether the data sets contained sufficient signal to estimate rates of evo-
lution (Table 2.1). Specifically, we confirmed that the lower bounds of the 95% confidence
intervals of rate estimates exceeded zero for all clades, which implied a gradual and measur-
able accumulation of mutations over the sampling time frame. Further, we assessed the model
fit with the coefficient of determination (R2), which was greatest for 01 AE and F1, and lowest
for subtype C (Table 2.1). Next, we employed a more robust least-squares dating method [20]
to rescale the trees in time. Table 2.1 summarizes the substantial differences between the strict
clock and least-squares estimates of the times to the most recent common ancestor (tMRCA)
for each clade.
We extracted pairs of cherries from these rescaled trees as phylogenetically-independent
observations on relatively short time frames. Next, we used these cherries to estimate the mean
2.4. Results 53
1980 1990 2000 2010
0.00
0.05
0.10
0.15
0.20
0.25
0.30
Collection Date
R
oo
t−
to
−T
ip
 B
ra
nc
h 
Le
ng
th
AE
a)
1980 1990 2000 2010
0.00
0.05
0.10
0.15
0.20
0.25
0.30
Collection Date
R
oo
t−
to
−T
ip
 B
ra
nc
h 
Le
ng
th
AG
b)
1980 1990 2000 2010
0.00
0.05
0.10
0.15
0.20
0.25
0.30
Collection Date
R
oo
t−
to
−T
ip
 B
ra
nc
h 
Le
ng
th
A1
c)
1980 1990 2000 2010
0.00
0.05
0.10
0.15
0.20
0.25
0.30
Collection Date
R
oo
t−
to
−T
ip
 B
ra
nc
h 
Le
ng
th
B
d)
1980 1990 2000 2010
0.00
0.05
0.10
0.15
0.20
0.25
0.30
Collection Date
R
oo
t−
to
−T
ip
 B
ra
nc
h 
Le
ng
th
C
e)
1980 1990 2000 2010
0.00
0.05
0.10
0.15
0.20
0.25
0.30
Collection Date
R
oo
t−
to
−T
ip
 B
ra
nc
h 
Le
ng
th
D
f)
1980 1990 2000 2010
0.00
0.05
0.10
0.15
0.20
0.25
0.30
Collection Date
R
oo
t−
to
−T
ip
 B
ra
nc
h 
Le
ng
th
F1
g)
Figure 2.1: The relationship between sequence root-to-tip branch lengths and sequence collec-
tion dates in seven clade-wise phylogenetic trees reconstructed from gp120 conserved region
(C1-C5) alignments. Each panel is labelled by the clade that its tree represents. All plot axes
have been adjusted to the same scales for comparison. Regions of greater color density indi-
cate the clustering of multiple plotted points. The solid line on each plot describes the linear
regression of branch lengths on collection dates.
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Root-to-tip LSD
Clade Rate ×10−3 tMRCA R2 Rate ×10−3 tMRCA
01 AE 2.49 (2.31, 2.67) 1971.4 0.51 1.87 (1.85, 2.10) 1968.6 (1965.5, 1974.6)
02 AG 2.21 (1.75, 2.67) 1957.4 0.35 2.27 (2.10, 2.68) 1961.9 (1957.5, 1969.0)
A1 2.69 (2.17, 3.21) 1932.0 0.26 2.45 (2.32, 2.66) 1966.3 (1964.0, 1969.5)
B 2.43 (2.32, 2.54) 1941.2 0.34 1.47 (1.46, 1.57) 1951.7 (1951.2, 1954.8)
C 1.99 (1.75, 2.23) 1926.9 0.13 1.80 (1.78, 1.96) 1939.8 (1937.5, 1946.7)
D 1.90 (1.47, 2.32) 1944.5 0.33 1.88 (1.68, 2.11) 1957.8 (1952.7, 1962.9)
F1 2.33 (1.85, 2.81) 1970.4 0.57 1.67 (1.34, 2.03) 1956.2 (1943.9, 1965.2)
Table 2.1: Summary of the evolutionary rate estimates, times to most recent common ancestor
(tMRCAs), and R2 values generated by applying root-to-tip and least-squares dating models
to our seven clade-specific trees. The 95% confidence intervals for the evolutionary rates of
both models and for the tMRCAs estimates of the LSD model are enclosed in brackets. Both
models are shown to illustrate the differences between fitting strict (root-to-tip) and relaxed
clock models to our sequence data.
indel rates for each variable loop using a binomial-Poisson model, where the probability of
detecting an indel event in a cherry increased exponentially with the divergence time. The
indel rate estimates across the five variable loops and seven HIV-1 clades in this study ranged
between 3.0 × 10−5 to 1.5 × 10−3 indels/nt/year (Figure 2.2). We could not obtain an indel
rate estimate for V3 in F1 due to low sample size for this sub-subtype, such that no cherries
had discordant sequence lengths in V3. Similarly, we observed wide confidence intervals for
the rate estimates for indels within V1 in 02 AG and F1, and for V5 in F1. The frequency of
indels was significantly lower in subtype B than the reference clade, 01 AE (binomial GLM,
p < 2× 10−16; Supplementary Table A1). In addition, indels were significantly less frequent in
V3 irrespective of clade relative to V1. Estimated interaction effects in the model also indicated
that indels were significantly less frequent than expected in V2 within clades B and C.
Under the assumption that differences in sequence lengths of variable loops was caused by
a single fixed indel (i.e., no multiple hits), we examined the distribution of indel lengths among
variable loops and clades. Cherries with putative indels in the HIV-1 subtype C phylogeny
tended to contain significantly longer indels than expected (Figure 2.3). Conversely, the vari-
able loops V1, V2 and V4 tended to contain longer indels than expected irrespective of clade,
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Figure 2.2: Indel rate estimates in the five gp120 variable loops of seven HIV-1 group M
clades. Each group of five colored bars describes the indel rates of V1-V5 for one of the seven
examined clades. Maximum likelihood estimation was applied to cherry indel outcomes using
a binomial-Poisson model to determine the above indel rates. Error bars represent the 95%
confidence intervals within which indel rates were estimated. Arrows labeled with a * symbol
indicate the presence and direction of significant differences among the mean indel rates of
group M clades, relative to the CRF 01 AE reference. Arrows labeled by a † symbol denote
significant differences among the variable loops irrespective of clade, relative to V1. Arrows
labeled by a ‡ symbol denote individual interactions between variable loop and clade which
are significantly different than their predicted value. No meaningful rate estimate was provided
for V3 of clade F1 because no indels were detected in this data set.
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whereas V3 and V5 tended to contain shorter indels.
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Figure 2.3: The distribution of indel lengths within (a) the seven group M clades and (b) the
five gp120 variable loops . Indel lengths, measured in nucleotides, were classified into three
categories: 3 nt, 6 nt, and 9 nt or longer. Box heights indicate the proportion of indels belonging
to the given length category, while box widths indicate the proportion of indels belonging to
(a) each clade or (b) each variable loop . Pearson χ2 residuals — quantified measures of the
difference between observed and expected values — were calculated for every group on these
plots to determine if, and in what direction, these proportions significantly deviated from the χ2
value. Pearson residuals are comparable to the number of standard deviations away from the χ2
value, meaning that values greater than 2, and especially those greater than 4, describe groups
whose proportions significantly deviate from the predicted outcome. Blue shading indicates
higher indel counts than expected, while red indicates lower counts.
Next, we examined the frequencies of nucleotides in indel- and non-indel regions of se-
quences in cherries with putative indels (Figure 2.4). Because these frequencies measured
for different clades tended to cluster by variable loop, we treated the clades as rudimentary
replicates for this comparison (notwithstanding sample variation associated with variable loop
V3 and subtype F1, for example). Overall, we observed that indels tended to contain higher
proportions of G and lower proportions of T than the corresponding non-indel regions.
Figure A1 summarizes the numbers of potential N-linked glycosylation sites (PNGS) de-
tected in each variable loop across the clades in our study. The mean counts in loops V1 to V5
were 2.4, 2.1, 0.9, 4.1 and 1.3 PNGSs, respectively. We found significant differences in PNGS
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Figure 2.4: Nucleotide proportions in indel sequences relative to flanking non-indel sequences
for all examined variable loops and subtypes. Plots (a-d) illustrate these relations in adenine,
cytosine, guanine, and thymine nucleotides, respectively. Each group denoted by a colored
shape represents one of the five variable loops of gp120 and contains seven data points corre-
sponding to each of the examined group M clades. The plotted line with a slope of 1 (y=x)
represents the null result in which sequences inside and outside of indels show no difference
in their nucleotide proportions. Plotted points that deviate from this line indicate differences
between nucleotide proportions found in indels compared to those found outside indels. Larger
data points indicate a significant χ2 test result testing for a difference between indel and non-
indel counts in that particular data set.
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counts among variable loops (likelihood ratio test, p = 2.8−13 ) and among clades (p < 10−15).
For variable loop V1, 01 AE contained significantly more PNGS (mean 2.93 PNGS) than the
other clades; the next highest count was obtained for subtype C (2.43 [95% C.I. 2.31, 2.57]).
Subtypes B and C had significantly higher numbers of PNGS within V3 on average (0.96 [0.87,
1.05] and 0.95 [0.96, 1.05], respectively) than the reference clade 01 AE (mean 0.81). We ob-
served substantial variation in the numbers of PNGS among clades in variable loop V4. For
instance, clades 02 AG, A1 and B had significantly higher numbers, and subtype F1 signifi-
cantly lower, than the reference clade 01 AE (mean 3.72). Finally, we mapped indels to PNGS
in the variable loop sequences to determine how frequently indels were associated with the ad-
dition or removal of a PNGS (‘disruption’, Figure 2.5). V1, V2, and V4 contained the highest
proportions of indel-induced PNGS disruption among the five variable loops. Again, we ob-
served that estimates for different clades visibly clustered by variable loop. When we adjusted
for the relative proportions of the variable loops occupied by PNGS, only V1 and V2 markedly
departed from this expectation.
2.5 Discussion
To our knowledge, these results represent the first comprehensive measurement of indel rates
in variable regions of HIV-1 gp120 across major virus subtypes and circulating recombinant
forms (CRFs). Surprisingly, one of the only estimates of HIV-1 indel rates we have found dated
back to 1995 [2], where Mansky and Temin used an in vitro assay of genetic mutations in HIV-1
reverse transcriptase (RT) and reported the observed counts of both nucleotide substitutions and
indels. In contrast, our comparative study measures indel rates among different hosts, and as a
result will inevitably underestimate these rates due to purifying selection on indels. We chose
to focus on cherry sequences derived from between-host data as it provided phylogenetically-
independent observations of indel evolution, while reducing the probability of multiple hits and
the effects of purifying selection. While the comparison of within-host HIV-1 sequences would
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Figure 2.5: The proportion of indels in a variable region that knocked out at least one PNGS,
relative to the PNGS content of the given variable loop. Data sets were represented by a
colored shape to denote their variable loop and contained seven points derived from the group
M clades. The dotted line of slope 1 provides a rough representation of the general trend
expected if PNGSs were under no selection. Individual points that did not cluster with their
variable loop were labeled with their clade. Specifically, V3 of subtype F1 did not have any
records of indel events.
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provide even shorter time scales and thereby more accurate measures of indel rates before
selection, some HIV-1 subtypes and CRFs remain underrepresented in publicly available, large
and longitudinal same-patient sequence data sets. In addition, results from Wood et al. [8]
suggest that purifying selection against indels is relaxed in the variable regions of HIV-1 gp120.
To estimate indel rates, we needed to accurately rescale the HIV-1 phylogenies in chrono-
logical time. Estimates of the tMRCA can vary by genomic region, and estimates from regions
within the HIV-1 gag and pol genes tend to be more recent than regions in env irrespective of
subtype [45]. Overall, we determined that the diversity of HIV-1 sequences and sample collec-
tion dates were sufficient to fit a strict molecular clock model (Table 1). We note that for the
purpose of rescaling the trees after this initial assessment with a strict clock, we employed an
implementation of a relaxed clock model that allows for rate variation over time. However, we
also observed that the goodness-of-fit used to assess support for the clock model was the lowest
for subtype C. We attribute this poor model fit to both the relatively old age of subtype C [46]
and the relative lack of HIV-1 C samples collected prior to 1995 (Figure 2.1). Estimates of
the times to the most recent common ancestor (tMRCA) from the relaxed clock model imple-
mented in the LSD program were generally comparable to previous estimates in the literature
for the corresponding HIV-1 clades [46, 47] except for subtype A1, for which we obtained a
more recent range of estimates (1964 to 1970). For instance, Tongo et al. [48] recently esti-
mated that (sub-)subtype A1 originated around 1946 – 1957 from an analysis of full-length
genome sequence data. We note that because our estimate relies on the ‘point estimate’ of
the phylogeny reconstructed by maximum likelihood, the confidence intervals reported for our
tMRCA estimates underestimate the true level of uncertainty and fixing the tree may skew the
mean estimate. A Bayesian method would more accurately capture this substantial source of
uncertainty, but would also be restricted to substantially reduced numbers of sequences due to
the complexity of sampling from tree space. Furthermore, Wertheim et al. [46] postulated that
estimates of tMRCA among studies may be inconsistent due to the use of nucleotide substitu-
tion models that are an inadequate approximation of past molecular evolution.
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Our estimates of region- and subtype-specific indel rates ranged from 3.0×10−5 to 1.5×10−3
indels/nt/year (Figure 2.2). As expected, our average estimate (5 × 10−4 indels/nt/year) was
considerably lower than the rate inferred from Mansky and Temin’s in vitro experiments (about
1.5 × 10−3 indels/nt/year) [2] , where we used parameter estimates from Perelson and Nelson
[49] to convert the observed numbers of indel counts to a rate. Since our study compares HIV-
1 sequences isolated from different hosts, the indels have been filtered by purifying selection
so that only a subset become fixed within the respective hosts. We found that indel rates
in subtype B gp120 were significantly lower than the reference clade 01 AE, and generally
lower than the other clades in our study. The significantly lower indel rate estimates in V3
irrespective of HIV-1 clade (Figure 2.2) were consistent with the functional importance of this
variable loop. As V3 contributes to HIV entry by binding to the CCR5 or CXCR4 coreceptors,
there is substantial purifying selection to conserve its overall structure [50, 51]. This lower
tolerance for mutational change, relative to other variable loops of gp120, is consistent with
reduced numbers of fixed indels among hosts. The lower indel rates might also be attributed in
part to compensatory mutations to preserve structural interactions in V3 [52]. For example, an
arginine insertion at position 11 of V3 confers CXCR4 tropism tends to be accompanied by a
single amino acid deletion near the C-terminal of V3 [38].
The tendency of HIV-1 subtype C to accumulate longer indels in our analysis is consis-
tent with results previously reported by Derdeyn et al. [37]. By examining HIV-1 heterosexual
donor-recipient pairs, Derdeyn et al. [37] first determined that subtype C viruses initially con-
tained shorter V1-V4 sequences upon transmission, which then substantially lengthened by
up to 25 amino acids after progressing to chronic late-stage infection. A follow-up study by
Chohan et al. [53] provided evidence that this trend was subtype-specific, as it was observed
in infections by subtypes A and C, but not subtype B. Similarly, the observed preference for
longer indels in V1 and V2 in our data is consistent with the role of these variable loops in fa-
cilitating immune evasion. For example, the insertion of five or more amino acids into V1/V2
is associated with reduced sensitivity of HIV-1 gp120 to neutralizing antibodies [54, 55], which
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is more efficiently achieved by a single long insertion than a series of short insertions. Con-
versely, the tendency for shorter insertions to accumulate in V3 is consistent with the existence
of functional and structural constraints as noted above.
The nucleotide composition of the HIV-1 genome is generally skewed to higher frequencies
of A (adenine), in large part due to G-to-A hypermutation induced by host factors [56]. We
have not found previous studies that have compared the nucleotide composition of indels to the
flanking sequence in the HIV-1 genome. Overall, we observed that indel sequences tended to
comprise higher frequencies of G and lower frequencies of T relative to the rest of the vari-
able loop sequence. We note that some frequency estimates had greater sample variation due
to limited numbers of indels and sequences in association with V3 and subtypes D and F, for
instance. Because the env gene generally contains slightly higher proportions of A (40%) and
lower proportions of G (18%) than the rest of the HIV-1 genome (35% and 24%, respectively),
we propose that this outcome might reflect the derivation of insertions into env from outly-
ing sequence. Since we have not individually resolved these numerous indels into insertions
or deletions through ancestral reconstruction, however, we cannot determine whether this pat-
tern reflects a tendency for sequence insertions to be G-rich, or whether G-rich sequences are
specifically targeted for deletion.
The variable regions of HIV-1 gp120 contribute disproportionately to the mean number of
potential N-linked glycosylation sites (11 out of 25), which make up the glycan shield of gp120
[57]. Overall, we found that the numbers of PNGS for each variable loop was fairly consistent
across clades, with some significant but minor differences in means (Figure A1). Furthermore,
we observed that PNGS were more frequently affected by indels in variable loops V1 and V2
irrespective of clade (Figure 2.5). Put another way, the proportion of indels affecting PNGS
in these variable regions was substantially greater than the proportion of the region encoding
PNGS. This outcome supports the hypothesis of diversifying selection for the addition or re-
moval of PNGS in V1/V2, where glycosylation plays a major role in mediating immune escape
[55] and transmission fitness [37] at different stages in the natural history of HIV-1 infection.
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Our estimates of indel rates in the variable regions of HIV-1 gp120 imply that fixed differ-
ences in variable loop lengths accumulate between infections on a time scale of about 10-20
years per variable loop with the exception of V3, which accumulates these differences an order
of magnitude slower. This time frame is consistent with past observations that HIV-1 gradually
‘raises’ the glycan shield with insertions in V1/V2 several years post-infection [55]. The accu-
mulation and composition of indels among infections is clearly heterogeneous among HIV-1
clades and variable loops. Some of the more exploratory results in this study, e.g., differences
in nucleotide frequencies within indels, are particularly novel and suggest new areas for further
research in the molecular evolution of HIV-1 to identify the biological or selective determinants
of sequence insertions and deletions.
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Chapter 3
Indel Evolution Within Hosts
3.1 Introduction
HIV-1 demonstrates an incredible capacity to evolve and diversify within hosts due to a vari-
ety of factors including its short generation time, high viral load, and rapid accumulation of
mutations such as substitutions, indels, and recombinations [1–4]. These factors also produce
a unique HIV-1 metapopulation structure within hosts, comprised of numerous smaller sub-
populations that exhibit a unique virus genotype [5–7]. Together, these characteristics make
the HIV-1 population a highly resilient, rapidly moving target capable of adapting to and over-
whelming the host immune system in the vast majority of infected subjects [8, 9]. For instance,
the acute phase of HIV-1 infection sees high counts of HIV-1 virus (roughly 107) generated in
the first 1-3 months, even though initial infection typically originates from just a single found-
ing virus [10, 11]. This is followed by an asymptomatic phase during which virus levels are
generally lower, but importantly, still undergo rapid turnover and adaptive evolution to host
immune responses [8, 9]. It is this adaptive evolution that enables HIV-1 to induce its final
disease outcome of AIDS, demonstrating the importance of studying within host evolutionary
processes [8].
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3.1.1 Sampling Differences
Importantly, the HIV-1 sampled in sequence data within hosts differs from the HIV-1 being
sampled among different hosts (one sequence per patient) in the population. For context, re-
call that the error-prone nature of HIV-1 replication and roughly 1010 new offspring produced
each day generate enormous diversity in the within-host population [12, 13]. HIV-1 research
conducted among hosts predominantly utilizes Sanger sequencing technology, as it provides a
single consensus sequence describing each individual’s virus population, in line with its objec-
tives. Sanger sequencing is unable to sample low frequency variants in the HIV-1 population,
meaning that mutations are required to reach sufficient prevalence (at least ∼ 20%) to be in-
cluded in the final sequence product [14–16]. Reaching sufficient prevalence involves enduring
extensive purifying selection over numerous viral generations, therefore making the final se-
quence a highly refined and filtered representation of the HIV-1 population.
On the other hand, sequence data sampled within individual hosts over time is predomi-
nantly generated using single genome amplification (SGA): a method that involves the serial
dilution of virus sample to concentrations low enough that individual virus genomes can be iso-
lated and sequenced. Instead of creating an average or consensus, SGA generates observations
of individual viruses which importantly, can include HIV-1 genetic variants present at lower
than 20% prevalence in the population. This means that many mutations, including indels,
can exist at low prevalence in patient HIV-1 populations and be detected using SGA, but will
often not reach high enough prevalence to be included in the final Sanger consensus sequence
when sampling among hosts due to purifying selection [16, 17]. For example, Wood et al. [18]
found numerous frameshift-inducing indels in the variable regions of gp120 using within-host
sequence data, while my previous study examining these same regions among hosts found es-
sentially no cases of frameshifts [19]. These sampling differences provided part of the rationale
for our choice to conduct a within-host phylogenetic analysis in this study having performed a
similar one among hosts previously (Chapter 2).
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3.1.2 Evolutionary Processes
Different processes shape the evolution of HIV-1 populations within hosts compared to that oc-
curring among hosts, which were discussed previously (Chapter 2). Within hosts, HIV-1 pop-
ulations predominantly undergo adaptive evolution in order to evade host immune responses, a
process which involves the successive fixation of advantageous traits driven by positive selec-
tion [2, 20–22]. Purifying selection is also present and responsible for filtering out mutations
that compromise virus functionality and thus confer a decrease in viral fitness [17].
On an among-host scale, recall that diversity here is strongly shaped by HIV-1 transmission
and its associated evolutionary pressures. This primarily involves strong population bottleneck
effects, as HIV-1 infection is established by only one or a few T/F variants [9]. In the pres-
ence of these stringent bottleneck effects, the process of reaching high prevalence or fixation
is essentially the only way a mutation can be transmitted to the new host and thus, plays a sig-
nificant role in modulating among-host variation [9, 16]. In fact, the relatively small fraction
of mutation successfully transmitted to a new host helps explain the higher evolutionary rates
of HIV-1 measured within hosts than those measured among different hosts in the population
[23, 24].
3.1.3 HIV-1 gp120
The above trends concerning evolution among and within hosts are particularly applicable to
the env gene that encodes the gp120 glycoprotein, given that it demonstrates the highest rates
of evolution and most abundant positive selection relative to other genes in the HIV-1 genome
[23, 25, 26]. Briefly recall that the gp120 gene is segmented into five conserved and five
variable regions, the latter of which encode five disordered loop structures on the exterior of
the protein. Additionally, the gp120 protein sequence contains numerous potential N-linked
glycosylation sites (PNGS) that form a dense glycan shield around this protein. In line with
among host evolution, there are reports that the glycan shield and variable loop lengths of
gp120 follow trends of transmission fitness, as transmitted HIV-1 tends to have shorter gp120
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variable loops and fewer N-linked glycosylation sites that lengthen and increase in number
over the course of infection, respectively [27]. The gp120 glycoprotein also follows trends of
within-host evolution, as demonstrated by its frequent accumulation of mutations that escape
the neutralizing antibody and CTL immune responses [28].
Immune Escape
Importantly, immune escape mutations, whether in gp120 or other HIV-1 genes, enable the
avoidance of HIV-1 neutralization in the circulation (antibody-mediated) or suppression during
infection of cells (CTL-mediated), therefore allowing HIV-1 to undergo replication normally
[29, 30]. These escape mutations can occur through multiple different pathways that involve
amino acid sites in both the conserved and variable regions of gp120 [31], though they are more
frequently found in the latter due to direct targeting by neutralizing antibodies [32, 33]. This
is demonstrated by studies finding immune escape mutations in the V1V2 regions [34, 35], V3
regions [21, 36], and V4 regions [33, 35, 37], for example. These escape mutations can come
in many forms including nucleotide substitutions, indel events, and changes to the positions of
N-linked glycans [26, 29, 34].
Rates
For one, the role of nucleotide substitutions in immune escape has been extensively studied in
gp120 [16, 29, 34, 35] and fittingly, so have the rates of substitutions in this gene [23, 38, 39].
The rates of mutations, such as substitutions or indels, are highly important and useful to the
study of virus evolution, as they provide an indication of how rapidly a pathogen evolves its
molecular sequence and thus, the speed at which it can respond to environmental pressures
[23, 40]. Therefore, faster evolution has been suggested to correlate with greater pathogen
resilience and quicker disease progression [13, 41, 42]. Furthermore, rates can also be used to
estimate evolutionary time scales and reconstruct common ancestry in phylogenetic inference,
which can be used to provide insights into a pathogen’s diversity, origins, and evolutionary
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patterns [43, 44].
3.1.4 Indels
Indels have also been shown to play a significant role in the generation of immune escape
variants in gp120, especially in the variable regions where they accumulate rapidly [27, 37, 45–
47]. Indels produce these escape variants by altering the physical structure of the variable loops
in several different ways, which include changes to amino acid compositions, overall variable
loop lengths, and changes to the number and positions of PNGS which control the glycan
shield [18, 34, 48]. However, despite the implicated role of indels in HIV-1 immune escape,
the estimation of indel rates had not yet been conducted within the env gene of HIV-1 prior
to my study present in Chapter 2. This study addressed this knowledge gap by estimating
among-host indel rates in the gp120 variable loops using a phylogenetic analysis of HIV-1
sequence data worldwide [19]. This work is important as it addresses the question of how
quickly indels are being fixed in the HIV-1 populations circulating in different people [19]. By
nature of the among-host sequence data utilized in this past study however, this study is unable
to examine the indels that either get removed from the population by purifying selection or
simply do not reach high enough prevalence to be included in the final sequence product [17].
The considerable differences in evolutionary pressures and type of sampled virus within hosts
compared to among hosts provided the rationale for this study. The study described in this
chapter seeks to address this unexplored topic by estimating gp120 variable loop indel rates
within hosts using longitudinally sampled patient data.
3.2 Hypothesis
I hypothesize that the rates of variable loop insertions and deletions can be determined on a
within-host scale using a dated phylogenetic analysis. Compared to my previous among-host
indel analysis, I postulate that insertion and deletion rates will be higher within hosts because
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these sampling approaches enable the detection of additional virus that has undergone less
purifying selection relative to that sampled among hosts [17, 19]. Given the predicted weaker
effects of purifying selection, I further expect to detect more indels that induce frameshift
mutations. Finally, I also predict that insertions and deletions will induce changes to N-linked
glycosylation site counts in the variable loops over the course of infection.
3.3 Methods
3.3.1 Sequence Retrieval and Processing
I first queried the Los Alamos National Laboratory HIV Database (LANL; http://www.hiv.lanl.
gov/) for HIV-1 sequences that covered gp120 and were derived from longitudinally sampled
patients containing at least 100 sequences. Sequence data downloaded from LANL contained
a total of 11,265 sequences, spanning 29 different research studies and 25 unique patients. In
the data, I found cases of redundancy where the same patient appeared in multiple studies.
Using a Python script, I compared redundant patient datasets and selected the single largest
one (if applicable) for the next stage of processing. At this point, I also checked for sequence
that did not cover roughly 90% of full-length gp120 (1400 nt), though no sequences registered
positive for this screen. Next, I needed to ensure that all patient sequences were consistently
labelled with an appropriate time value. Consistent time-stamping of all sequences was crucial
for later analysis, as these values were used to rescale phylogenetic trees in time and provide
the basis for indel rate estimates. Naturally, research studies authoring these patient data on
LANL had a variety of different aims, meaning that collection date measures were inconsistent
between studies. The different time measures found in LANL-derived datasets included: the
number of days since first sample, treatment start, infection start, and seroconversion. I am
aware that these different scales could describe considerably different periods of HIV-1 infec-
tion. However, we deemed any of these four time scales sufficient for this study given that
subsequent analysis would be conducting a full reconstruction of HIV-1 evolutionary history
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within hosts and rescaling time estimates while doing so. For patient datasets annotated with
more than one time scale, I chose the time scale that had the widest coverage of sequences,
and fewest negative or incomplete entries. I also removed patient datasets that spanned less
than 200 days and contained fewer than five unique sampling timepoints to ensure that datasets
provided sufficient coverage of HIV-1 infection.
I then needed to check whether any data were derived from DNA sequences because HIV-1
DNA can be an ineffective measure of within-host evolution when a patient is receiving anti-
retroviral therapy (ART). When a patient is receiving ART, HIV-1 replication is suppressed and
the virus is not able to integrate its viral DNA into the genomes of CD4+ cells, thus prohibiting
detectable evolution in these sampled sequences. All patient datasets in the study were found
to contain HIV RNA sequence data, with the exception of one patient data set which contained
only HIV-1 DNA. Upon further investigation of this data set, we found that the corresponding
patient was not receiving ART, indicating that the patient’s DNA sequences were undergoing
evolution and suitable for use in our analysis.
I also received an additional 2,541 HIV-1 gp120 sequences from Dr. Vlad Novitsky at
Harvard University. These sequence data were derived from 25 patients also sampled using
SGS and provided coverage from V1 to C5 of gp120. Unlike the LANL-derived sequence data,
these sequences did not include the first conserved region of gp120 (C1) and therefore, required
slight modifications to initial alignment and extraction procedures. All gp120 sequences from
the Novitsky Lab were labelled with a consistent date indicating the days past seroconversion,
requiring no further screening efforts in this regard.
Nucleotide sequences from both sources were sorted into individual FASTA files on a per-
patient basis using unique identifiers in the header of each sequence. This produced an initial
data set of 6,717 sequences sampled across 44 patients.
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3.3.2 Sequence Slicing and Alignment
The next step of my pipeline removed sequence outside the gp120 gene and recorded the loca-
tions of the five gp120 variable regions. To accomplish this, I performed pairwise alignments
using a Python-based implementation of the Gotoh algorithm as modified by Altschul and Er-
ickson [49] (http://github.com/ArtPoon/gotoh2). I aligned every gp120 nucleotide sequence in
my patient datasets against the gp120 sequence of HXB2 (Genbank Acession: K03455), which
recall, is the reference sequence of HIV-1 subtype B. Using the HXB2 annotations, I then cut
patient nucleotide sequences at the boundaries of the aligned boundaries of gp120 to remove
extraneous flanking regions that did not overlap with the gp120 gene. Next, I removed all gap
characters from this result, translated it into its amino acid sequence, and aligned it to the HXB2
gp120 protein sequence. Using the locations of gaps in the protein alignment, I then inserted
gap triplets (i.e. – – –) into the corresponding locations of the patient’s nucleotide sequence
in order to generate codon-based nucleotide sequence alignments. We opted for this approach
to address issues in locating the exact nucleotide boundaries of the variable loop sequences,
which were believed to be caused in part by the abundance of mutations present. Using the
HXB2 reference annotations, I searched our codon-based nucleotide alignment and recorded
the sequences and locations of the five gp120 variable regions in every patient sequence for
later analysis.
I ran MAFFT (version 7.271) [50] with default settings on each set of patient-derived gp120
sequence data to generate multiple sequence alignments (MSA) describing within-host diver-
sity.
3.3.3 Patient Screening for Phylogenetic Analysis
I then used the Randomized Axelerated Maximum Likelihood program (RAxML) version
8.2.11 to reconstruct ML phylogenetic trees describing within-host gp120 evolution [51]. Re-
call that a phylogenetic tree is a model of evolutionary history governed by multiple parameters,
such as the evolutionary rate and branching order (topology). The next step was to root these
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ML phylogenetic trees, as the current unrooted trees do not describe the ancestry or direction
of evolution among tree lineages. While multiple tree rooting methods exist, I used the root-to-
tip regression function made available in the Analyses of Phylogenetic and Evolution (APE) R
package to root my phylogenetic trees [52].
Molecular Clock Signal
Next, I proceeded to gauge the strength of the same molecular clock signal in my patient
datasets. An important step in my study involves the generation of time-scaled phylogenetic
trees, i.e. trees whose branch units have been rescaled to units of time, such as days or years.
Scaling a phylogenetic tree in time requires the presence of molecular clock signal in the data
and therefore, the inclusion of patients in forthcoming analyses is contingent on their sequence
data exhibiting sufficient clock signal. I generated a root-to-tip regression on each within-
host ML tree and excluded patient datasets with an R2 value below 0.30, which removed an
additional 13 patients from the analysis.
Hypermutation
The hypermutation of HIV-1 sequences refers to an abundance of G to A nucleotide substi-
tutions and is primarily caused by an intrinsic anti-viral mechanism in human cells involving
the protein APOBEC3G [53]. Hypermutation can cause problems in HIV-1 sequence analysis
(i.e. introduction of premature stop codons) and thus need to be removed [54]. I therefore,
screened the 32 remaining patient datasets for sequences containing G to A hypermutation us-
ing a local implementation of the Hypermut Analysis Tool made available by LANL [54]. To
conduct this analysis, I generated a consensus sequence from the sequence data collected at
the first sampling timepoint and used it as the reference for this analysis. We opted to use a
consensus generated from the first timepoint because it would approximate a relatively older
ancestral sequence and thus allow the directionality of substitutions to be determined (i.e. G in
ancestor −→ A in descendant). In one patient data set (LANL ID: 30651), Hypermut flagged
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approximately 35% of all sequences as hypermutants. To investigate this result, we first re-
viewed the metadata describing this patient data set in its study of origin and found that no
evidence of hypermutation had been reported. [55]. I then manually examined this patient’s
multiple sequence alignment, but no grouping of distinct sequences displaying signs of hyper-
mutation could be found. Given the sufficient clock-like signal and lack of any highly divergent
sequences, we elected to skip the hypermutation screen in this patient.
Superinfection
Next, I manually inspected patient MSAs and phylogenetic trees for signs of co-infection or
superinfection. One patient (LANL ID: 111848) showed signs of superinfection based on the
presence of two distantly related populations in its phylogenetic tree evolving over the same
sampling time points. Upon referencing the original study, we confirmed that this patient had
a highly heterogeneous infection and contained extensive recombination [56]. We opted to
exclude this patient from the study given the multiple complications that would arise from the
two divergent HIV-1 populations and numerous recombinant sequences contained in the data
set. The screens for superinfection, hypermutation, and molecular clock signal produced a data
set containing 4,573 sequences from 30 patients.
3.3.4 Phylogenetic Tree Reconstruction
I then reconstructed phylogenetic trees using Bayesian Evolutionary Analysis Sampling Trees
(BEAST) v1.10.4 [57]: a software framework that uses Bayesian statistical inference to re-
construct phylogenetic trees under a variety of models. Briefly, Bayesian inference in BEAST
first involves placing a prior probability distribution (starting estimate or guess) on each of the
tree parameters [57]. From here, BEAST implements a Markov chain Monte Carlo (MCMC)
algorithm: an algorithm that draws a (typically large) number of samples from a probability
distribution, where each step only depends on the previous one, in order to approximate its
characteristics [57]. Markov chain Monte Carlo methods are useful for sampling probability
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distributions in highly complex model systems, often involving multiple parameters. BEAST
uses MCMC to sample tree parameter values according to their posterior probability: the prod-
uct of the value’s prior probability and the likelihood of the observed data given the parameter
values. As a result, the density of values sampled through MCMC will be proportional to the
parameter’s posterior distribution (final result). This MCMC sampling procedure is performed
for every tree parameter, including the tree topology itself. Importantly, BEAST analysis also
incorporates time data to scale phylogenetic trees in time and thus depends on the presence of
molecular clock signal which I screened for earlier.
Parameters
I performed two analyses on each patient in BEAST, each of which ran for 100 million MCMC
iterations [57]. The use of MCMC in a Bayesian framework allows BEAST to fit numerous
models to the data that facilitate the effective reconstruction of time-scaled phylogenies. For
one, I fit a TN93 model of evolution to the data, which includes parameters describing nu-
cleotide frequencies and three different rate parameters: one for nucleotide transversions and
one for each type of transition [58]. I also fit a Gamma site heterogeneity model, which ac-
counts for differences in the substitution rate between nucleotide positions in the sequence by
assuming that the rate at each position is randomly drawn from a Gamma distribution [59]. For
the molecular clock, I fit a uncorrelated relaxed clock model, which allows each tree branch
to adopt an evolutionary rate independent of other branches (thus uncorrelated) that is drawn
from a log-normal probability distribution [60].
Posterior Convergence
In order for BEAST output to be deemed sensible and valid, the posterior distributions of tree
parameters were required to exhibit sufficient convergence on a single value (i.e. spending
the majority of steps close to a single value and not substantially deviated from it). However,
roughly 12 patient analyses had abnormally high clock rates often accompanied with large
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variance, causing poor convergence of multiple other tree parameters. I attempted to fix this
by 1) setting narrower prior distributions on the mean and standard deviation parameters gov-
erning the relaxed clock model, 2) setting an upper bound on the analysis, and 3) setting the
start value closer to evolutionary rates approximated by the root-to-tip regression analysis con-
ducted previously (1E−5 − 1E−4). These attempts however, only partially fixed convergence
problems and so we deemed it necessary to constrain the tree topology during BEAST analysis
in order to get working results. Normally, BEAST is able to change the topology, or branching
order, of the phylogenetic tree during analysis to explore a wide variety of possible tree con-
figurations. Constraining the topology involves restricting BEAST analysis to sample a single
tree structure determined by a preset guide tree, which in this case, was the ML tree generated
using RAxML. This greatly improved convergence by reducing analysis complexity while still
allowing BEAST to focus on the optimal scaling of branch lengths, which were central to our
estimation of indel rates.
Coalescent Model & Model Selection
In BEAST, I also fit a coalescent model to the phylogenetic tree — a model describing how
genetically-distinct lineages originate from points of common ancestry [61]. The coalescent
model permits estimation of a phylogeny’s effective population size (Ne), which is essentially
the size of a theoretical population that would demonstrate identical traits to the real one under
the model assumptions [62]. The Ne provides an estimate of how population demographics are
changing over time and can be used to compare between evolutionary models [62]. The con-
stant coalescent model is the most basic of these models which assumes that the Ne remains
constant throughout evolutionary history [61]. In BEAST, there have been several advance-
ments to the coalescent model that, for example, allow the population size to vary between
coalescent events and apply a smoothing algorithm over the population trajectory. Of these
extensions, I decided to use the recent Skygrid coalescent model. Importantly, this model con-
tains a parameter called the number of population sizes: a user-defined number specifying how
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many times the Ne to allowed to change throughout the tree. As the most modern development,
the Skygrid model provides the greatest flexibility of the existing coalescent model versions.
For each patient’s data set, use of the Skygrid model first required justification that this
model was preferred over the constant coalescent using model selection criteria, i.e. demon-
strating the model provided a sufficiently better fit to this patient’s data than the constant coales-
cent while accounting for its higher complexity. For those patients that fit the Skygrid model,
I further sought to determine the number of population sizes that best suited their sequence
data, as these patient datasets had differing time periods of infection. Accounting for both of
these factors, I conducted model selection between the constant coalescent model and Skygrid
models containing 10, 20, and 30 population sizes using the Bayes factor: the ratio between
the likelihood values (probability of the data given model parameters) of the two model fits
[63]. Importantly, there were rare instances where the model selected by the Bayes factor con-
ferred poor posterior convergence of tree parameters. Since posterior convergence is essential
to consider results legitimate, we cannot trust the Bayes factor to determine the most appropri-
ate model in these cases, and so I selected the model with the next highest Bayes factor that
conferred sufficient posterior convergence.
Skygrid cutoff values — a parameter indicating how far back in time the coalescent model
will reconstruct infection — were set to 125% of the estimated RAxML tree root height to
cover the entirety of infection. Of the 60 BEAST analyses performed (2 per patient), 24 runs
used the constant coalescent while 9, 22, and 5 runs used the Skygrid model containing 10,
20, and 30 population sizes, respectively. Brief tests involving fewer than 10 and more than 30
population sizes were commonly met with poor convergence.
Tree Extraction
I extracted phylogenetic trees from the BEAST analyses in two different ways to address sepa-
rate objectives in my study. First, I randomly sampled 200 phylogenetic trees from the posterior
distribution of each patient’s BEAST analysis for the purposes of determining indel rates and
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timings during infection. Two BEAST analyses were conducted per patient, resulting in a to-
tal of 400 trees/pat. We chose this approach because these analyses involved continuous time
data and used methods that could incorporate numerous data points to estimate distributions
of the results. The other approach involved extracting the single posterior tree selected by a
branch length consensus algorithm. A single tree was deemed suitable for the remaining anal-
yses on lengths, compositions, and PNGS changes because these analyses dealt with discrete
observations of indel sequences. This branch length consensus (BLC) tree was selected by first
generating a distance matrix relating the branch lengths of all posterior trees, determining the
centroid position of this matrix (i.e. the mean position across all branch length dimensions),
and finding the tree with the lowest Euclidean distance to this centroid position. The tree se-
lected using this method will be closest to the theoretical center of the distribution of sampled
trees, meaning that it will have one of the highest posterior probabilities.
3.3.5 Ancestral State Reconstruction & Indel Extraction
The next step involved extracting insertions and deletions from the phylogenetic trees sam-
pled from the posterior of BEAST analysis by reconstructing the ancestral state sequences
within these trees. For this task, I chose to use the Historian v0.1 ancestral reconstruction soft-
ware package because of its incorporation of optimized algorithms from other modern software
packages, its effective reconstruction of indels, and its accuracy in estimating evolutionary rates
[64]. After receiving a MSA as input, Historian attempts to reconstruct a phylogenetic tree to
conduct its analysis. Given that I already reconstructed trees in BEAST, I turned off phyloge-
netic reconstruction in Historian and used my own trees as a guide for analysis. I performed two
separate analyses in Historian as my phylogenetic trees were now stratified into two formats:
the 400 randomly sampled posterior trees, and the single modified BLC tree from each pa-
tient’s BEAST run. We encountered errors when running Historian on the four largest patient
datasets, which persisted despite tuning parameters to lessen the complexity of the analysis.
This prevented 4 patient datasets from completing their analyses in Historian, resulting in a
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fully finalized data set containing 2,668 sequences from 26 patients. When stratified by HIV-1
group M subtype, there were 2,452 subtype C sequences across 24 patients and 216 subtype B
in 2 patients.
The output of Historian is a MSA relating all tip and ancestor sequences in the phylogenetic
tree. Therefore, to extract indels, I recursively iterated through the within-host tree to identify
pairs of sequences connected by a branch (i.e. every ancestor-descendant pair). I then scanned
through the aligned variable regions in the Historian output using locations determined in my
previous in-frame pairwise alignment with HXB2 gp120. Insertions presented as nucleotides
that were only found in the descendant, while deleted nucleotides were only present in the
ancestor.
Subtype:
o C  = 2,452 seqs, 24 pat
o B  = 216 seqs, 2 pat
Los Alamos National 
Laboratory HIV Database
(n = 11,265, 25 pat)
Novitsky Lab
(n = 2,541, 25 pat)
Screen for redundancy and
sampling coverage
(n = 6,717, 44 pat)
Screen for molecular 
clock signal
(Root-to-tip regression)
(n = 5,668, 31 pat)
Screen for hypermutated 
sequences (Hypermut)
(n = 5,577, 31 pat)
Screen for superinfection 
and extensive recombination
(n = 4,573, 30 pat)
Ancestral Reconstruction 
(Historian)
(n = 2,452, 24 pat)
Rate & Time Analyses
(Subtype C only)
Phylogenetic Reconstruction 
(BEAST)
Composition, Length, 
PNGS Analyses
(Subtype B & C)
Ancestral Reconstruction 
(Historian)
(n = 2,668, 26 pat)
400 trees / patient 1 BLC tree / patient
Figure 3.1: Summary of data sourcing, filtering, and analyses in this study. BLC refers to
branch length consensus trees found by determining the tree with the lowest Euclidean distance
to the mean across all branch lengths.
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3.3.6 Indel Rate Estimation
I first retrieved the indel count and time-scaled length associated with every tree branch in
the 400 randomly sampled trees of the 24 subtype C patients (n=2,452). I then used the R
implementation of Stan (RStan) v2.19.1, a modern statistical inference platform for conducting
Bayesian inference, to fit a hierarchical model to this data and thereby estimate indel rates in
our within-host data. This hierarchical model consisted of multiple layers to account for the
stratification of data in this study. First, the model fits a Poisson generalized linear model to
the counts of indels (y) along the branches of a single phylogenetic tree. The Stan framework
then samples the mean count parameter as a product of the branch-associated time values (t)
and a single indel rate (r) describing the tree. We decided that a Poisson GLM was most
appropriate for this analysis given that the indel count data exhibited highly similar mean and
variance measures, an intrinsic assumption of the Poisson distribution. The following equation
describes the probability of observing indel counts y on branch k in one tree, given the time-
scaled branch length t and the overall rate of the tree r.
P(yk | r, tk) =
(rtk)yk e−(rtk )
yk!
(3.1)
By generating a single indel rate estimate per one tree (r), I accumulate 400 tree-based indel
rate estimates within one patient (r j...r400). The hierarchical model then fits these 400 rates to
a normal distribution describing a single patient i and samples the mean (µ) and variance (σpat)
parameters governing this distribution.
P(r j | µi, σpat) = 1σpat
√
2π
e−
1
2
(
r j−µi
σpat
)2
(3.2)
This process is performed once for each patient in the study to generate 24 patient means
(µi...µ24). Finally, the model then fits these 24 patient means to another normal distribution
describing all of subtype C and again, samples the mean (ω) and variance (σsub) of this subtype-
level distribution.
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P(µi | ω,σsub) = 1σsub
√
2π
e−
1
2
(
µi−ω
σsub
)2
(3.3)
The final result that I am estimating is the mean indel rate ω of HIV-1 subtype C. A sum-
mary of the entire hierarchical model is shown below, in which case distributions are simplified
in the following manner: normal(mean, variance), Poisson(mean).
µi ∼ normal(ω,σsub) (3.4)
r j ∼ normal(µi, σpat) (3.5)
yk ∼ Poisson(r j × tk) (3.6)
I fit this hierarchical model in RStan, sampling for 104 MCMC iterations, in order to esti-
mate insertion and deletion rates separately in each of the five gp120 variable loops (V1-V5).
Additionally, I wanted to determine whether indels events accumulate more frequently in the
recently-sampled terminal branches of the phylogenies, and so further I stratified each variable
loop indel rate by internal and terminal branches in the tree. This produced one internal and
terminal rate estimate per variable loop for insertions (2 × 5) and for deletions (2 × 5).
3.3.7 Indel Timings
While extracting indel events along tree branches, I also retrieved the cumulative branch length
from the root of the tree to the midpoint of that branch. Phylogenetic inference aims to recon-
struct the entire evolutionary history dating back to the root, or start of infection. Therefore,
these cumulative length values in units of days represent the time since the start of infection
when insertions and deletions occurred.
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3.3.8 Nucleotide Composition
Next, I wanted to examine trends in nucleotide compositions within insertions and deletions.
For this analysis and forthcoming ones, I applied Historian software to the BLC tree of each
BEAST analysis to reconstruct ancestral state sequences and extract indels in these trees. Im-
portantly, this involved use of the full data set which contained 26 patients and 2,668 sequences
across subtypes A1, B and C. Using an R script, I collected insertions and deletions, stratified
them by variable loop, and compared their nucleotide compositions to their variable loops of
origin. To check for significant differences in these results, I performed randomization tests
on the insertions and deletions in each variable loop. For every indel, I randomly sampled 100
nucleotide fragments of the same length from the variable loop where the indel occurred. I then
determined whether the cumulative nucleotide proportions of the indels (size n) were above or
below the 95% quantiles of the proportions of the randomly sampled fragments (size 100n).
3.3.9 Indel Lengths
Using the BLC tree, I examined the distribution of insertion and deletion lengths across the
five gp120 variable loops. I wrote a custom R script that further stratified variable loop indels
into seven different length categories. To detect significant differences, I utilized the ‘mosaic’
plot function made available by the ‘vcd’ R package on my data [65]. This function examines
the Pearson chi-squared residuals of every bin in the contingency table (5 variable loops × 7
length categories) to detect counts that are significantly higher or lower than expected.
3.3.10 Changes to Potential N-linked Glycosylation Sites
I then sought to determine whether insertions and deletions added or removed PNGSs in
the gp120 variable loops more frequently than expected by chance. Recall that previously,
I scanned all branches of the within-host phylogenetic trees to extract the exact sequences and
locations of indel events in the variable loops. While this provided information about the in-
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dels themselves, I also needed to determine the locations and numbers of PNGSs in the variable
loop protein sequences. For every ancestor and tip sequence in each tree, I translated the vari-
able loops to their amino acids sequences and searched them for PNGS motifs using the regular
expression ‘N[ˆP][S T ][ˆP]’, where ‘[ˆP]’ will match any amino acid except proline. At this
point, I had information about all indels on tree branches and the counts of PNGSs in every
ancestor and tip sequence.
This analysis required the comparison of two components: the observed and the expected
changes in PNGS counts induced by indels. At every indel event in the tree, I first determined
the number of PNGSs in the affected variable loop before and after the indel occurred (i.e. in
the ancestor without the indel and the descendant containing it), and recorded the differences in
these counts. Importantly, I made adjustments to ancestor-descendant sequence pairs to isolate
for the effects of individual indels. In cases where multiple indels occurred on the same branch,
I selected a single indel to analyze, kept all the others in the sequence, and determined PNGS
counts with and without the one indel of interest. I chose to include other indels in the sequence
because I was specifically interested in examining how each indel contributed to PNGS counts
in context of all the others. For example, it might be that one indel does not add or remove a
PNGS on its own, but might do so when placed in tandem with a second indel. Additionally,
I also controlled for substitution events as a potential source of PNGS creation or deletion by
reverting all polymorphisms to match the ancestral sequence before examining the indel. The
results were the observed changes to PNGS counts induced by indels.
To estimate the indel-induced PNGS changes expected by chance, I performed a random-
ization test using the indels collected in the data. This approach involved placing every indel
back into its variable loop sequence of origin 500 times in randomized locations, sampling with
replacement. Using the same process as before for observed PNGS changes, I then calculated
the differences between ancestor and descendant PNGS counts on this new randomized data.
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3.4 Results
3.4.1 Indel Rates
I retrieved a total of 2,452 longitudinally-sampled gp120 sequences from LANL and the Novit-
sky Lab and subject them to phylogenetic reconstruction in BEAST to generate time-scaled
trees describing within-host HIV-1 infections. I then reconstructed ancestral state sequences
of 400 posterior BEAST trees to extract insertion and deletion events, and fit a Poisson-based
hierarchical model to time and indel count data using Bayesian inference in RStan in order to
estimate the insertion and deletion rates of the gp120 variable loops. Median insertion rates in
terminal branches ranged between 4.3 × 10−5 and 2.0 × 10−3, while those on internal branches
were between 4.3 × 10−5 and 4.1 × 10−3 (Figure 3.2). On the other hand, median deletion rates
ranged between 5.6 × 10−5 and 6.4 × 10−3 on the terminal branches, and between 4.3 × 10−5
and 9.6×10−3 (Figure 3.2). The rates of both insertions and deletions appeared to be highest in
V1 and V5, slightly lower in V2 and V4, and substantially lower in V3. Overall, deletion rates
appeared to be higher than insertion rates in V1, V2, and V5 based on the distances between
the 95% confidence intervals (Figure 3.2). Rate estimates based on the internal phylogenetic
tree branches also appeared higher than those based on the terminal branches in particular cases
such as: indel rates in V1, indel rates in V5, and only insertion rates in V4 (Figure 3.2).
3.4.2 Indel Timings
While extracting indels from within-host phylogenies, I also collected the cumulative time-
scaled branch length from the tree root to the midpoint of the branch containing each indel.
I collected these time values in order to estimate the distribution of insertion and deletion
timings over the course of infection, which is displayed in Figure 3.3. The first 800 days of
infection sees small and large increases in insertion and deletion counts, respectively (Figure
3.3). Interestingly, deletions reach a frequency above 2.0 events/200 days/patient during this
time frame, followed by a gradual decrease and stabilization at approximately 1.0 deletion/200
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Figure 3.2: Posterior median estimates of within-host insertion and deletion rates in the five
gp120 variable loops of HIV-1 subtype C. Rate estimates are further stratified based on data re-
covered along terminal and internal branches within intrapatient phylogenetic trees. A Poisson-
based hierarchical model accounting for 400 trees per patient across 24 patients (400×24) was
sampled for 104 Hamiltonian Monte Carlo (HMC) iterations using an RStan Bayesian infer-
ence framework. Error bars represent the 95% confidence intervals of the indel rate distribution
describing HIV-1 subtype C.
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days/patient (Figure 3.3). Insertions exhibit lower counts than deletions throughout infection,
peaking at just over 1.0 event per 200 days in the first 400 days and subsequently decreasing
throughout the rest of infection (Figure 3.3).
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Figure 3.3: The mean counts of insertions (blue) and deletions (red) collected per patient within
every 200 day interval since the estimated start of infection (tree root). Associated indel timings
were based on the cumulative time-scaled edge distance from the root of the tree to the midpoint
of the branch where the indel occurred. To account for the differences in infection duration, I
applied a correction factor to higher time intervals as fewer datasets became available.
3.4.3 Indel Lengths
For remaining analyses, I extracted insertions and deletions from the BLC tree selected from
the posterior distribution of each patient’s BEAST analysis. Upon collecting these indels, I first
examined trends in the length distributions of insertions and deletions as shown in Figure 3.4.
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Interestingly, there were significantly elevated counts of insertions and deletions that were a)
longer than 9 nucleotides in length in V1, b) 6 nucleotides in length in V2, and c) 3 nucleotide
in length in V5 (Figure 3.4). Relatively long insertions (> 9 nt) were significantly elevated
in V4, while long insertions and deletions were significantly less frequent in V5 (Figure 3.4).
We also detected negligible counts of insertions or deletions in V3 with lengths longer than
3 nucleotides as expected. Frameshift-inducing lengths were very rare in both insertions and
deletions, comprising 4.2% and 4.5% of these populations, respectively (Figure 3.4).
3.4.4 Indel Nucleotide Compositions
I then estimated the nucleotide proportions of insertions and deletions extracted from each
patient’s BLC tree to investigate whether indels differed in compositions from the variable
loop sequences where they occur. Nucleotide compositions of both insertions and deletions
showed little to no deviation from those of their variable loops of origin (Figure 3.5). Similar
results were observed when investigating indel dinucleotide proportions, which also essentially
matched those in their variable loops (Supplementary Figure B2). I noticed a relatively small
increase in proportions of G within insertion sequences relative to the variable loops, but a
randomization test did not find this increase to be significant (Figure 3.5). Further stratification
of nucleotide proportions by variable loop revealed that these higher proportions of G in inser-
tions are primarily found in V2 and V5 (Supplementary Figure B1a). Guanine proportions in
insertions were also higher than those in deletions, though we did not investigate this further
given the small magnitude of this difference (Figure 3.5).
3.4.5 Indel-Induced PNGS Changes
Using regular expressions, I recovered the positions of PNGSs within the variable loop se-
quences throughout BLC trees and using this information, determined how frequently indels
induced the addition or removal of these sites. I then compared the observed indel-induced
PNGS changes to those expected under stochastic processes to test the hypothesis that indels
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Figure 3.4: The lengths of insertions (a) and deletions (b) across the five variable loops of
HIV-1 gp120. Indel counts are stratified into seven length categories: blue-colored bins de-
scribe in-frame lengths (3, 6, 9), red-colored bins describe frameshift-inducing lengths (not
a multiple of 3), and dark gray bins describe very long indels (> 9 nt). Pearson chi-squared
residuals — standardized differences between observed and expected counts — were gener-
ated for every length category in both plots. Bins that are wider and narrower that the outlined
column margins indicate counts that are significantly higher and lower than expected, respec-
tively, based on Pearson chi-squared residuals. Bins matching the column margins in width
showed no significant differences.
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Figure 3.5: Nucleotide compositions of variable loop insertions (©) and deletions (4) relative
to their surrounding non-indel loop sequence. Error bars represent the 95% confidence inter-
vals for estimates of nucleotide proportions, acquired by regenerating nucleotide proportions
in randomly sampled subsets of the data 1000 times. Point sizes are proportional to the square
root of nucleotide counts detected within the given mutation event. As x and y axes are iden-
tical, points that deviate above and below the line indicate higher and lower proportions of the
given nucleotide in indels, respectively. I tested for significant differences using a random-
ization test, which involved 1) sampling each variable loop sequence 100 times for substrings
matching the size of the indel, 2) pooling these substrings together, 3) calculating the nucleotide
proportions on this null distribution of variable loop samples, 4) and testing whether observed
insertion/deletion nucleotide proportions were above or below the 95% quantiles of this distri-
bution. No nucleotide proportions in either insertions or deletions registered as significantly
higher or lower based on this test.
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tend to add or remove PNGSs more often than expected by chance (Figure 3.6). On average,
insertions in V1 and V4 increased PNGS counts in their variable loops significantly more often
than expected by chance. Insertions in V2 also demonstrated a similar significant trend, albeit
to a lesser extent. Specifically, insertions in V1, V2, and V4 removed 0.53, 0.23 and 0.32
PNGSs on average when placed randomly, while instead causing the addition of roughly 0.32,
0.09 and 0.40 PNGS when observed in the data (Figure 3.6). Deletions in V1 and V4 frequently
removed PNGSs, though these changes were roughly comparable to those expected from ran-
dom placement (Figure 3.6). Insertions in V5, and deletions in V2, V3, and V5, showed less
prominent tendencies to add or remove PNGS, which also showed little difference relative to
the changes generated at random. Insertion in V3 did not induce any observed changes to
PNGS counts and were thus excluded from this result.
3.5 Discussion
3.5.1 Indel Rates
Here, I present the first estimates of insertion and deletion rates in the gp120 variable loops of
HIV-1 subtype C measured within hosts. Our approach involved the inference of time-scaled
phylogenetic trees and subsequent reconstruction of tree ancestral sequences in order to study
insertions and deletions over the course of HIV-1 infection. While Mansky and Temin [4] pro-
vided an indel mutation rate of HIV-1, rates of indel evolution had not yet been studied in env,
nor using time-scaled phylogenetic approaches prior to my study in Chapter 2 [19]. This study
addressed this knowledge gap by providing the first estimates of gp120 variable loop indel rates
in seven group M subtypes of HIV-1 using sequence data sampled among hosts [19]. Unlike
my previous among-host study, this study estimates insertion and deletion rates independently
of each other and utilizes indel events retrieved throughout the entire phylogenetic tree, instead
of just the tip sequences [19]. I hypothesized that within-host insertion and deletion rates would
be higher than those measured among hosts due to lessened purifying selection that has acted
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Figure 3.6: Changes to the counts of potential N-linked glycosylation sites (PNGSs) in the
variable loops induced by insertions and deletions. On the x axis, I estimated changes to
PNGS counts expected by chance by placing every indel back into its variable loop sequence of
origin 500 times in randomized locations. The y axis on the other hand, describes the changes
to PNGS counts observed in the collected data. Given the identical axes, points above and
below the line indicate that indels from specific variable loops tend to increase and decrease the
PNGS counts more often than expected by chance, respectively. Error bars represent the 95%
confidence intervals acquired by randomly sampling from the final distribution of observed and
expected changes 1000 times. Point sizes are scaled to the square root of the number of indel
events in the given category. No estimates could be generated for the insertions of V3 due to
insufficient data.
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on these sequence data. I found support for my hypothesis, as within-host indel rates in subtype
C appeared considerably higher in V1, V2, V4, and V5 than those measured among hosts given
the distinct separation from the 95% confidence intervals (Figure 3.2, Figure 2.2). Addition-
ally, I noticed that both insertion and deletion rates in this study exhibit the same trends across
variable loops as in my among-host study: indel rates in V5 and V1 were relatively high, those
in V2 and V4 were relatively moderate, and rates in V3 were relatively low (Figure 3.2, Figure
2.2). This almost identical trend in indel rates among variable loops does not offer support for
our hypothesis that within-host sequence data has undergone far less purifying selection. If
we were looking past purifying selection, we would expect to see higher indel rates in loops
intolerant to mutation (i.e. V3) due to the removal of this strong filtering effect, and even higher
rates in V1 and V2 due to their heavy involvement in immune escape [34, 66].
When comparing deletions to insertions, deletion rates in V1, V2, and V5 appear signif-
icantly higher than insertion rates based on the distinct separation of the 95% confidence in-
tervals (Figure 3.2). Interestingly, Cheynier et al. [67] reported collecting four times as many
deletions than insertions in V1 of a strain of SIV, showing a similar trend to the ratio between
our deletion and insertion rates in this variable loop (5.0:1.1 in terminal branches, and 6.0:2.7
in internal branches; Figure 3.2) . This suggests that SIV may hold similarities regarding the
accumulation of insertions and deletions in the variable loops of its surface protein. There are
also interesting implications of higher deletion rates (Figure 3.2) when considering the similar
length distributions of insertions and deletions (Figure 3.4). Based on the trends displayed in
Figure 3.4, insertions and deletions appear to be roughly the same length on average, meaning
that these findings together suggest that the variable loops are in fact shrinking over time. A
possible explanation for this phenomenon is the selection of shorter variable loops to enhance
the efficiency of HIV-1 binding to susceptible immune cells during acute infection [68]. More-
over, the patients examined in this study may have severely weakened immune systems which
would further exacerbate this trend [66]. A weak immune system would exert minimal selec-
tive pressure on the gp120 variable loops to lengthen, causing them to instead shrink due to the
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fitness advantages associated with more efficient fusion [66].
When stratifying indel rates by internal and terminal branches, we expected to find higher
indel rates in the terminal branches on average based on our hypothesis. We hypothesized
that our within-host sequence data has undergone relatively little purifying selection and on
this basis, terminal branches should contain additional indels from malfunctioning or non-
functional viruses that have not been filtered out by purifying selection. Internal branches
on the other hand, are required to have successfully replicated in order to be sampled, likely
reducing the potential to detect indels. However, we found higher indel rates in the internal
tree branches relative to those in the terminal branches in V1, V5, and to a limited extent
in V4, which contradicted our expectations. As discussed previously with deletion rates, this
could be explained by selective pressures driving the accumulation of indels during early stages
of infection when the HIV-1 population undergoes more rapid evolution [13]. Alternatively,
in a population dynamics context, this could be caused by the HIV-1 population undergoing
periods of exponential growth during early infection, which would present as very short internal
branches in our time-scaled trees that may overestimate rates [69]. In fact, I observed this exact
trend in my finalized trees sampled from the posterior of BEAST analysis, supporting this as a
possible cause for the elevated internal branch indel rates. While these offer plausible biological
explanations for our findings, we also cannot exclude the possibility of intrinsic bias towards
shorter internal branch lengths introduced by RAxML and BEAST.
3.5.2 Indel Timings
Using the same posterior trees, I also estimated the time at which variable loop insertions and
deletions occurred using the cumulative time-scale branch lengths of the phylogenetic trees.
The slight and large increases in variable loop insertion and deletion counts, respectively, dur-
ing the first 1500 days of infection shows concordance with existing knowledge of the evo-
lutionary processes occurring during this time period of HIV-1 infection. The asymptomatic
phase of HIV-1 infection often starts 2 to 10 weeks after the start of HIV-1 infection (< 100
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days) and typically lasts 7 to 10 years (2550 - 3650 days) [8, 9]. Recall that HIV-1 undergoes
substantial adaptive evolution during this phase, which involves the positive selection of im-
mune escape variants [8, 9, 30]. In context of HIV-1 infection timings, these results appear to
support the notion that variable loop deletions, and insertions to a lesser extent, are involved
in the adaptive evolution of HIV-1 in the asymptomatic phase (100 - 2500 days), possibly
through the generation of immune escape variants (Figure 3.3) [34, 45, 47]. Lee et al. [13]
has demonstrated that HIV-1 substitution rates undergo a similar trend to indel frequencies in
Figure 3.3, in that these rates often decline in the later years of HIV-1 infection (i.e. 4-10 years)
when CD4+ cell counts decrease in number. The concordance in these findings suggest that
indel rates are correlated with substitution rates and possibly even correlated with CD4+ cell
count, though further research will be needed to confirm this [13]. These findings however,
still have notable uncertainty and may in fact, be artifacts generated by biases in phylogenetic
reconstruction, as mentioned previously.
3.5.3 Indel Lengths
Using the single BLC from each patient’s BEAST analysis, I then examined trends in insertion
and deletion lengths. I found remarkably few cases of frameshift-inducing insertion (4.2%) and
deletion (4.5%) lengths within hosts, which suggest that purifying selection exerts substantial
effects within hosts (Figure 3.4). Interestingly, I found a relatively and significantly increased
proportion of 6-nucleotide insertions in V3, which is surprising given the stringent conserva-
tion of this loop due to its functional involvement in coreceptor binding [70]. Aside from this,
the seeming intolerance of insertions or deletions longer than 6 nucleotides in this loop still
aligned with our expectations and corresponded with its previously established conserved na-
ture [70]. The significantly elevated counts of long insertions (> 9 nt) in V1 corresponds with
previous reports that the V1V2 loop lengthens and gains PNGS over the course of infection
in response to neutralizing antibody responses (Figure 3.4) [27, 45, 46]. The length of these
insertions matches the length increases reported in the V1V2 loop structure and importantly,
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are also of sufficient length to add entire PNGSs to the loop sequence (3-5 amino acids) (Figure
3.4) [27, 45, 71]. It is however, surprising that the same abundance of long insertions is not
observed in V2, given that the same trends are also expected to affect this loop (Figure 3.4)
[45, 71]. Fascinatingly, we see a remarkable number of long deletions in V1 that even exceeds
the number of long insertions in this variable loop. To reconcile this finding with the trends
of V1V2 growth during infection, I postulate that these large deletions could occur relatively
early in infection as shown in Figure 3.3, or undergo removal or reversion driven by purifying
selection, thereby allowing V1V2 to lengthen later in infection using insertions. Furthermore,
the remarkably lower tolerance for long deletions (> 9 nt) observed in V2 relative to V1 is sur-
prising, given that it is the longest variable region (120 nt) and has been reported to accumulate
numerous indels throughout infection [34, 35, 45, 71].
3.5.4 Indel Nucleotide Compositions
I also found that the nucleotide compositions of both insertions and deletions essentially matched
those found in their variable loops of origin (Figure 3.5). These findings loosely suggest that
the nucleotides comprising insertions originate from somewhere in the HIV-1 genome, given
the distinctly high proportions of A and low proportions of C found in both sources (Figure
3.5) [72]. Regarding deletions, these findings suggest that there are no relative differences in
the fitness costs of maintaining each of four nucleotides in the variable loop sequences, since
all nucleotides have a roughly equal propensity to be deleted (Figure 3.5). The slightly higher
proportions of A (∼ 0.40) and lower proportions of G (∼ 0.17) relative to those found in both
the subtype C consensus sequence (GenBank Accession: U46016) and reports by van der Kuyl
and Berkhout [72] (A: 0.36, G: 0.24) suggest that some G to A hypermutation was undetected
by our Hypermut analysis screen [72].
3.5. Discussion 103
3.5.5 Indel-Induced PNGS Changes
I found that insertions in V1, V4, and to a lesser extent, V2 tended to create new PNGSs,
and also demonstrated a tendency to do so more frequently than expected by chance (Figure
3.6). These findings align with previous reports that indels in V1, V2 and V4 tend to add
and change the positions of PNGS to generate glycan shield variants to escape neutralizing
antibody responses over the course of infection [27, 37, 45, 46]. Moreover, the stark differences
in observed and expected changes in V1, V2, and V4 suggest that insertions are under strong
selection to avoid disrupting existing PNGS and instead add new sites (Figure 3.6). Deletions
in V1 and V4 demonstrate tendencies to remove PNGSs, but unlike insertions, show minimal
signs of selection acting on their placement given that they induce changes that align with
stochastic processes (Figure 3.6). These results also contextualize our findings of significantly
elevated proportions of long insertions in V1 and V4 (Figure 3.4), suggesting that these PNGS
changes are primarily driven by relatively long insertions that may add partial or entire PNGSs
at a time [27, 37, 45].
3.5.6 Limitations
An important limitation to consider in this study is our constraint of tree topology during
BEAST analysis. Different tree topologies, which would have been explored in typical BEAST
analyses, may change the distributions of indel counts and timings associated with tree branches,
both of which are used in the estimation of indel rates. Therefore, searching multiple tree
topologies favoured by posterior probabilities would provide a more comprehensive estimation
of indel rate variation and uncertainty. However, recall that there was insufficient molecular
clock signal in my data to generate sampling convergence for the posterior distributions in
BEAST in this more complex tree parameter space. Since posterior convergence is essential to
consider BEAST outcomes valid, we deemed constraining the tree topology necessary in order
to generate working results. At the same time, this constraint of topology is likely causing an
underestimation of the uncertainty surrounding indel rates and may further be systematically
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biasing these estimates in some way.
3.5.7 Conclusions
This study contributes to the understanding of indels in the gp120 variable loops on a within-
host scale, which comprise an important evolutionary mechanism driving HIV-1 adaptation
through immune escape. We found that indel rate estimates appeared higher on a within-host
scale than those estimated among hosts in a previous study, suggesting support for our hy-
pothesis (Figure 3.2) [19]. However, further investigation into the caveat of constraining tree
topologies during BEAST analysis will be needed to confirm this finding. Interestingly, we
find rare instances of frameshift-inducing insertion and deletion lengths (4.2%, 4.5% respec-
tively) in our within-host analyses, demonstrating that purifying selection is highly prevalent
within hosts (Figure 3.4). Nucleotide compositions of insertions and deletions were essentially
indistinguishable from those recorded in the surrounding variable loop sequences, loosely sug-
gesting that insertions do not have a distinctly different origin and that nucleotides are not being
selectively deleted (Figure 3.5). Finally, we find that insertions in V1, V2, and V4 appear to
undergo selection for those that introduce new PNGS sites, while deletions tend to remove
PNGS in a rather stochastic manner (Figure 3.6).
By estimating indel rates, we provide a quantified measure of the evolution introduced
by indels in the variable loops, which was previously unknown and can be used in future
comparative studies. Given the suggested role of variable loop indels in immune escape, indel
rates may also correlate with HIV-1 disease progression or CD4+ cell decline, in a manner
similar to substitution rates [13, 41, 42]. Future research on indel rates however, will be needed
to investigate these putative correlations. We hope that our quantification of variable loop indel
rates will facilitate further research into HIV-1 indel rates and lead to the further incorporation
of indels into evolutionary analyses.
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Chapter 4
Insertion Modelling
4.1 Background
In this chapter, I will describe the future directions for my phylogenetic analyses on indels,
as well as my current work on these ideas to date. Having extracted numerous insertion and
deletion events from the variable regions of patient-derived gp120 sequences, we wanted to
take further advantage of this opportunity by building an empirical model that effectively de-
scribes these indels. An empirical model is a simplified statistical representation of a real-world
process or mechanism which is importantly, based on observed data [3, 4]. At its core, an em-
pirical model is a set mathematical relationships between one or more variables that capture a
set of statistical assumptions and as a whole, form an overarching hypothesis about the system
[4]. Being a pragmatic approximation of reality, an optimized empirical model can recreate
the outcomes of relatively complex mechanisms and contribute to a more fundamental under-
standing of the modelled system. Thus, modeling of insertions and deletions has potential to
improve understanding of the underlying mechanisms that generate these mutational processes
and their contributions to sequence evolution.
Insertions and deletions are capable of inducing more genetic change on a per-nucleotide
scale than substitution events and are therefore, suggested to have a crucial role in sequence
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evolution [5]. Despite their implicated importance, indels have been investigated and utilized
to a lesser extent than nucleotide substitutions, likely due in part to the inherent difficulty
surrounding their reconstruction [1]. This difficulty stems from the fact that indels cannot be
directly observed like nucleotide substitutions; their positions can only be inferred, which leads
to greater uncertainty [1, 11]. For example, while substitutions form the basis of evolutionary
models and have been studied extensively over the last five decades, the use of indels for evo-
lutionary analysis remains a newly expanding area of research, though some groups have made
promising recent advances [5, 7, 8, 12]. This demonstrates the need for additional research
on indels in multiple areas which importantly, is not solely limited to their application to evo-
lutionary models. This includes research into the underlying mechanisms that control indel
generation in molecular sequences, which can be facilitated through the empirical modelling
and includes my modelling efforts here.
Generally, there are two different hypothesized mechanisms of indel generation in molec-
ular sequences. For one, the strand slippage mechanism involves the shift of the template or
copying strand during replication, leading to their misalignment and the misincorporation of
one or more bases [6]. A slip in the template will cause one or more nucleotides to form a loop
which cannot be recognized by the polymerase enzyme, leading to the deletion of base pairs in
the loop [6]. Contrarily, if the copying strand slips backward to form its own loop, it will copy
redundant nucleotides and result in the insertion of new base pairs [6]. A second proposed
mechanism, which has been proposed to occur frequently in HIV-1, occurs during the recom-
bination between two genetic sequences [2, 9, 10]. Recall that in this process, a polymerase
enzyme will dissociate from its attached template in the middle of replication, attach to another
nearby template and continue copying on the new template [2, 9, 10]. If the polymerase does
not attach to the new strand at the same location that it was copying on the original strand, it
can lead to the deletion or insertion of nucleotides if it attaches in front or behind its original
position, respectively [2, 9].
Here, I describe my work developing an empirical model describing indels in the variable
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loops of HIV-1 gp120. To accomplish this, I used Bayesian inference to fit various model
structures and parameters to the indel data collected during my within-hosts study (Chapter
3). By testing, comparisons, and refining different models in this framework, I hypothesize
that the trends in indel lengths, compositions, and frequencies can be recreated and different
hypothetical indel generation mechanisms can be compared. In its current state, this chapter
constitutes my efforts to model the strand slippage mechanism pertaining solely to insertions.
I chose to focus on modeling insertions first due to a unique set of findings displayed in Fig-
ure 4.1. Interestingly, I found that both insertions and deletions were frequently flanked by
an identical, or mostly identical, sequence immediately upstream or downstream of the event
(Figure 4.1). Insertions followed this trend to a greater extent than deletions did, with 20.6%
of recovered insertions having an adjacent exact match (Figure 4.1a) and 36.6% having a more
lenient match where 1 in 9 nucleotides are allowed to differ (Figure 4.1c). Given these findings
and being relatively new to empirical modeling, I decided that modeling insertions as a product
of replication slippage was an appropriate starting point.
118 Chapter 4. InsertionModelling
Insertion - Exact Match Distance
Distance from Insertion Site (nt)
0 5 10 15 20 25 30
0.00
0.05
0.10
0.15
0.20
0.25
D
en
si
ty
a) Deletion - Exact Match Distance
Distance from Deletion Site (nt)
0 5 10 15 20 25 30
0.00
0.05
0.10
0.15
0.20
0.25
D
en
si
ty
b)
Insertion - Rough Match Distance
Distance from Insertion Site (nt)
0 5 10 15 20 25 30
0.0
0.1
0.2
0.3
0.4
D
en
si
ty
c) Deletion - Rough Match Distance
Distance from Deletion Site (nt)
0 5 10 15 20 25 30
0.0
0.1
0.2
0.3
0.4
D
en
si
ty
d)
Figure 4.1: The minimum distance, in both the 5’ and 3’ directions (upstream and downstream),
to the next perfect sequence match for insertion (a) and deletion (b) sequences. The same scan
was repeated for “rough” matches for both insertions (c) and deletions (d), in which 1 in every 9
nucleotides was allowed to be a mismatch. Results with a distance of 0 nt importantly indicate
that a match was detected immediately adjacent to the indel, either in the 5’ or 3’ direction.
Densities indicate the percent of matches found at the given distance, and account for indels
with no match found.
4.2. Methods 119
4.2 Methods
4.2.1 Insertion Data
For this modelling task, I used the insertion sequence data retrieved from the branch length
consensus trees of my within hosts study in Chapter 3. Recall that a single consensus tree was
selected from the posterior distribution of each patient’s analysis in BEAST by generating a
distance matrix of branch lengths and selecting the tree closest to the centroid, or central point
describing the mean across all branch lengths. Insertions were retrieved by recursively iterating
over every branch of a phylogenetic tree and performing pairwise comparisons between each
ancestor and descendant sequence. Importantly, I recorded the insertion sequence, its location,
the full descendant sequence containing the insertion, and the full ancestor sequence lacking
it. This yielded 923 insertion sequences from 64 different phylogenetic trees.
4.2.2 Bayesian Framework
In order to fit models to my data in a modular and customizable fashion, I opted to code a
custom Metropolis-Hastings Markov Chain Monte Carlo (MCMC) algorithm in R to conduct
Bayesian inference. Recall that MCMC sampling can be used to sample from a target probabil-
ity distribution to approximate its characteristics which, in this case, is the posterior distribution
of each empirical model parameter. In this framework, I utilize the Metropolis-Hastings algo-
rithm, which first randomly samples a new proposed value (or step) and then chooses to accept
or reject this proposal. The algorithm always accepts proposals with a higher probability than
the current position and accepts lower probability ones with a random chance proportional to
their decrease in probability. The algorithm I coded here is functionally equivalent to that uti-
lized in BEAST to sample the posterior distribution of phylogenetic tree parameters, albeit in a
more simplified format. Use of this statistical framework provided great flexibility when fitting
more complex models in subsequent model advancements. Generally, model experimentation
involves determining the model parameters, specifying the appropriate prior distribution on
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each parameter, specifying the details of the proposal algorithm (that is, the code responsible
for generating a new proposed change to parameter values), and finally, testing the model on
simulated data generated using a known process (i.e. to test a geometric model, I will simulate
data using a randomized geometric process).
4.2.3 Fundamental Assumptions
To model insertions as the products of replication slippage, I first needed to make certain as-
sumptions about how this model system will work. I should note that additional assumptions
were required for subsequent model developments, but here I will highlight the core ideas that
remained constant throughout the modelling process. Firstly, I assumed that every insertion se-
quence of length n is the product of n ‘slip events’, each of which involve the polymerase and
copying strand slipping backward on the template sequence by 1 nucleotide. Correspondingly,
standard genetic sequence outside of insertions of size n was also assumed to be the product
of n successful ‘copy events’ that add 1 nucleotide at a time, in line with standard nucleotide
replication mechanisms. We opted to deconstruct insertions and standard sequences into sin-
gle nucleotide events in order to account for all possibilities of insertion lengths observed in
the data. Also, we referenced replication literature and found no basis that might suggest the
slippage of a nucleotide strand would demonstrate a tendency to occur in units larger than 1
nucleotide [6]. Under these assumptions, I could convert the variable loop sequences contain-
ing insertions into a sequence of copy and slip events. Since I was focused on modeling the
counts of slip events, all copy events were converted into an absence of slip events and slip
events were pooled together as shown below (i.e. 0 slips).
a) Copy / Slip Events: C C C S S S C C C S S S C C C
b) Slip Counts: 0 0 0 3 0 0 0 3 0 0 0
Figure 4.2: Format of data used as input for empirical models of insertion.
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4.3.1 Single Parameter Models
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Figure 4.3: Posterior distributions of two different single-parameter models, both sampled for
106 MCMC iterations on simulated data in a custom Bayesian framework. In the model shown
on top, slip events are assumed to be geometrically distributed based on a single underlying
parameter describing the probability of slipping: P(slip). Normal copy events are considered
successes while slip events are considered failures, so that the probability of success is 1 −
P(slip). In the bottom model, slip events are assumed to follow a Poisson distribution governed
by a single parameter “lambda” (λ) describing the mean count of slip events per nucleotide.
In both models, the dashed black line represents the true value used to generate the simulated
data, while the red line describes the prior distribution used for the analysis.
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My initial attempts to model insertion sequences involved fitting models containing a single
parameter to my insertion data. The first model assumed that there was a constant underlying
probability of slipping at each nucleotide which was described by a geometric distribution.
Equation 4.1 describes the geometric distribution which captures the probability of seeing x
number of slip events, given s the probability of slipping in a sequence (modified so that s =
1 − p where p is the probability of successfully copying). I generated the corresponding log-
likelihood function of s shown in Equation 4.2 — which describes the total likelihood of seeing
the observed counts x1 through xn given the slip probability s — to evaluate the posterior
distribution of this parameter using Bayesian inference. The results of this simulated test are
shown in Figure 4.3 (top).
f (x | s) = (1 − s)sx (4.1)
logL(s) = n ln(1 − s) +
 n∑
i=1
xi − n
 ln(s) (4.2)
My second single-parameter model assumed that the number of slip events at each nu-
cleotide position was generated through a Poisson process. Equation 4.3 refers to the Poisson
distribution that describes the probability of seeing x slip events, given the mean count of slip
events across all nucleotides: λ. I then utilized the Poisson log-likelihood function shown in
Equation 4.4 to determine the posterior distribution of λwhich is shown in Figure 4.3 (bottom).
f (x | λ) =
λxeλ
x!
(4.3)
logL(s) =
n∑
i=1
xi ln(λ) − nλ (4.4)
The two single parameter models showed strong convergence; however, there were notable
shortcomings due to their simplicity as expected. When trying to simulate new insertions
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using the geometric or Poisson processes, the distribution of simulated lengths was strongly
biased towards very short lengths of 1, 2 and 3 (not shown), which vastly differed from my
observed insertion data (Figure 4.4). Both the geometric and Poisson distributions assume that
the probability of each event (a slip in this case) occurs independently from other events and
therefore, having 3 slip events occur at the same nucleotide has the probability of (1−s)×s×s×s
(Equation 4.1). From here, we were confident that the model needed additional complexity to
simultaneously account for the very low frequency of starting a slip event and the long insertion
lengths that can be generated, as shown in Figure 4.4.
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Figure 4.4: The lengths of insertions retrieved in the five variable loops of HIV-1 gp120 across
26 patients. For each patient, insertions were recovered from a branch length consensus tree
selected from the posterior distribution of BEAST analysis.
4.3.2 Two State Model
For subsequent modelling, I opted to utilize a model that has two different states: a copy
state during which a nucleotide is replicated normally, and a slip state that inserts an additional
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nucleotide into the sequence (Figure 4.5). This model has two parameters governing movement
between the states: a probability of entering the slip state (enter) and a probability of staying
in it (stay; Figure 4.5).
Copy Slip
P(Enter)
P(Stay)
1 - P(Stay)
1 - P(Enter)
Figure 4.5: Schematic depicting a two state model mechanism governed by two parameters:
the probabilities of entering and staying in the slip state. The probability of staying in the
current state and moving to the other can differ based on the current state.
The independence of these two parameters addresses the primary shortcoming of the single-
parameter models by permitting the frequency of insertions to be low, while generating rela-
tively long insertion lengths. Under this model, the descendant sequence containing the inser-
tion is deconstructed so that every nucleotide is assigned to one of the two model states based
on whether it is part of the standard variable loop sequence or an inserted sequence. Impor-
tantly, these states then dictate the series of sequential steps through the two state model system
(Figure 4.5). For example, if the sequence of states is “copy, copy, slip, copy”, then we know
that the steps taken were 1) staying in the copy state, 2) entering the slip state, and 3) leaving
the slip state. Since every step through the model system has an associated probability, I can
then calculate the likelihood for this series of events given the model parameters. The log-
likelihood of a given descendant sequence containing an insertion (x) is given by the following
formula:
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logL(x | E, S ) = a ln(1 − E) + b ln(E) + b ln(1 − S ) + c ln(S ) (4.5)
where E is the probability of entering the slip state, S is the probability of staying in the
slip state, a is the number of regular copying events, b is the number of insertions, and c is
the cumulative number of nucleotides in insertions excluding the first nucleotide (i.e. insertion
length −1).
Nucleotide Substitutions
I then added the capability to account for nucleotide substitutions. Up to this point, I was fitting
my two-state model to the descendant sequences of tree branches that had just acquired a new
insertion sequence. To account for nucleotide substitutions in the model however, I needed
to compare each descendant sequence to that of its immediate ancestor. This data was read-
ily available considering that I saved both the ancestor and descendant sequences along each
branch of the tree containing an insertion. Importantly, this does not affect the two state model
mechanism as it continues to read the descendant sequence containing the insertion as normal.
Inclusion of ancestral sequences allowed me to incorporate a Felsenstein ‘81 model of evolu-
tion into my empirical model in order to calculate the likelihood of the observed nucleotide
substitutions. Although the Felsenstein ‘81 model has four parameters (three describing nu-
cleotide frequencies and one rate; πA, πC, πG, µ), I opted to fix the nucleotide frequencies to
those estimated in my data set and allow the remaining substitution rate to become the third
parameter in my model system. I generated simulated sequence data using a rate for substitu-
tions and a two state system for insertions (Figure 4.6).
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Figure 4.6: Posterior probabilities of three parameters describing the empirical model of in-
sertion sequences. The three parameters shown here are 1) the probability of entering the slip
state, 2) probability of staying in the slip state, and 3) the rate of nucleotide substitutions. The
model was run for 2×105 MCMC iterations on simulated data in a customized Bayesian frame-
work. The dashed vertical line indicates the true value used to simulate the data, while the red
horizontal line indicates the prior probability set on each model parameter.
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Length Bias
I then sought to account for the strong bias towards inframe insertion lengths in the observed
data by including a probability parameter called ‘fixation’ (Figure 4.4). Firstly, this parameter
operates under the assumption that inframe insertions are under no purifying selection, while
those that induce frameshifts experience strong pressures. This fixation parameter describes
the estimated proportion of frameshift-inducing insertions observed in the data, or in other
words, the proportion of frameshifts that are successfully reach fixation and are not removed
by purifying selection. To incorporate this parameter, we devised an algorithm that uses the
model parameters and the number of inframe insertions (assumed to be unaffected) to calculate
the theoretical total number of frameshift-inducing insertions that would exist in the data if
purifying selection was fully absent. I then use the observed frameshift insertion count and this
theoretical total to sample the binomial probability of observing a frameshift in the data (i.e.
observed frameshifts / total theoretical frameshifts).
Random Walk of Slip Events
Given that indels cannot be observed directly and only reconstructed through inference, there
is always the possibility that the reconstructed positions, lengths or counts of indels in an
alignment does not match those in reality. Knowing this, I added functionality to my model
that allowed it to change the positions of slip events within genetic sequences to explore other
configurations of insertions. For example, with 3 slip events in the same location, the model
can move one slip event to evaluate the likelihood of having two insertions of length 1 and 2
a few nucleotides apart. This algorithm essentially lets the model treat the positions of slip
events as additional parameters that it can adjust and re-evaluate. Importantly, this mechanism
relies on the likelihood calculated by the Felsenstein ‘81 substitution model, as the movement
of slip events will shift the sequence and greatly affect the number of perceived substitutions.
Proposed slip positions will cause favourable increases in F81 likelihood if they facilitate the
alignment of more nucleotides and minimize substitutions. Likewise, positions that induce mis-
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alignments that generate more substitution events will be unfavourable due to a corresponding
drop in likelihood. This mechanism added considerable complexity to the model, as it essen-
tially sought to realign sequences by moving inserted nucleotides.
The current model implements a two-state mechanism, substitution rate parameter, fixation
probability, and a random walk of slip events. Simulated results run for 2e5 MCMC iterations
are shown in Figure 4.7.
Figure 4.7: Posterior probabilities of four parameters describing the finalized empirical model
of insertion sequences. The four parameters shown here are 1) the probability of entering the
slip state, 2) probability of staying in the slip state, 3) the rate of nucleotide substitutions, and
4) the probability of seeing a frameshift-inducing insertion length (fixation). The model was
run for 2 × 105 MCMC iterations on simulated data in a customized Bayesian framework. The
dashed vertical line indicates the true value used to simulate the data, while the red horizontal
line indicates the prior probability set on each model parameter. Importantly, this model run
involved the initial shuffling and subsequent reconstruction of independent slip events.
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4.4 Discussion
Indels are an important mutational mechanism given their significant contributions to molec-
ular sequence evolution [5]. Though indels bring inherent difficulties in their reconstruction,
they have been shown to provide substantial benefit to phylogenetic inference methods, es-
pecially those pertaining to rapidly evolving pathogens [11]. Here, I present my efforts to
generate an empirical model describing the insertions sequences retrieved in the variable loops
of HIV-1 gp120 as the products of a replication slippage mechanism [6]. The resulting model,
demonstrated in Figure 4.7, represents my work up to this point. Overall, the model is able
to simulate nucleotide substitutions and insertions in sequences in a manner that reasonably
reflects the trends observed in patient-derived sequence data. The use of a two-state model
system provided the flexibility needed to capture the unique trends of very rare insertion events
that were simultaneously quite long (Figure 4.4). Importantly, my model is able to account
for the strong bias against frameshift-inducing insertion lengths, through the incorporation of
a penalty parameter (fixation) (Figure 4.7). Although this mechanism still requires tuning, my
model is also able to explore additional insertion configurations by moving independent slip
events (Figure 4.7). It has demonstrated a moderate capacity to reconstruct the positions of
insertions observed in the data as well (not shown). Importantly, this work should be consid-
ered with its scope in mind, as it focuses on cases of indels in a specific genetic region of a
particular virus. That being said, I believe my work will contribute to better understanding of
indel characteristics and enable more in-depth research into the mechanisms that govern their
creation.
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Chapter 5
Conclusions
5.1 Overview
Overall, indels remain a relatively understudied topic in HIV-1 research, despite having pro-
found effects on sequence variation in the HIV-1 genome. My work in this dissertation con-
tributes to this topic by estimating the rates and characteristics of indels in the variable loops
of HIV-1 gp120, and generating an empirical model to describe these mutations. Of the many
investigations performed in this work, the estimation of indel rates formed the core of this
study. While Mansky and Temin [4] estimated an in vitro indel generation rate across the HIV-
1 genome, rates of indel evolution had not yet been estimated in HIV-1 prior to this work.
Moreover, no studies have estimated rates of indel evolution in the variable loops of gp120
where indels are abundant and play a biologically significant role in the generation of immune
escape variants. I address this particular knowledge gap here by providing the first estimates of
indel rates and other characteristics in the gp120 variable loops using dated phylogenetic anal-
yses of patient-derived HIV-1 sequence data. Furthermore, I conducted these analyses on both
an among-host and within-host scale by utilizing different sequence data and methods. We had
reasonable basis to expect different results when examining indels on these two different scales
because of the considerable differences in evolutionary forces and sampling techniques among
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hosts compared to those within hosts. Finally, I extend my efforts by developing an empirical
model that describes the observed indel data collected in my within-hosts study.
5.2 Summary of Findings
Foremost, this work reports unique and novel findings of gp120 variable loop indel rates within
and among hosts. On an among-host scale in Chapter 2, we detected that HIV-1 subtype B
exhibited significantly lower variable loop indel rates than the reference clade AE and generally
lower than the other examined clades (Figure 2.2). Within-host indel rate estimates in Chapter
3 appeared significantly higher than those estimated among hosts in all variable loops except
V3 (Figures 2.2 and 3.2). In our within-host study, we also found that deletion rates appeared
significantly higher than insertion rates in these same variable loops: V1, V2, V4, and V5
(Figure 3.2). The apparent shrinking of these variable loops could be explained by selection for
higher fusion efficiency, which could be further enhanced by relatively weak immune systems
in the examined patients. Additionally, we found that within-host variable loop indels tended
to accumulate more frequently during the earlier stages of infection based on the higher indel
rates of internal branches (Figure 3.2) and the dating of indels earlier in infection (Figure 3.3).
This suggests that indels undergo strong selection during the acute stages of HIV-1 infection,
but could also be the result of bias within our analyses.
Next, I found interesting trends on the topic of indel lengths. No frameshift-inducing in-
del lengths could be detected on an among-host scale, while 4.2% and 4.5% of insertions and
deletions, respectively, adopted these lengths on a within-host scale (Figure 3.4). The lack
of frameshifts on an among host scale was expected due to sequences having undergone sub-
stantial purifying selection at this level. However, the low proportions of frameshifts on a
within-host scale suggests that there is still notable purifying selection acting on intrapatient
datasets and thus contradicts our hypothesis.
I also report interesting findings regarding indel-induced changes to the number of PNGSs
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in the variable loops of gp120. On an among-host scale, we find that indels in V1 and V2
either added or removed PNGS more frequently than expected (Figure 2.5). A similar, more
detailed analysis within hosts further revealed that deletions affected PNGS in a relatively
random manner, while insertions in V1, V2, and V4 tended to add PNGS more often than
expected by chance (Figure 3.6). This corroborates existing reports on indels by showing
that insertions appear to undergo positive selection to add PNGSs in the variable loops, likely
causing them to increase in prevalence within HIV-1 populations [1, 2, 6]. Overall, these
findings better characterize the role of indels in changing the glycan shield of gp120, and in the
case of insertions specifically, provide quantified estimates that reflect the selective pressures
they experience (Figure 3.6).
5.3 Concluding Hypotheses
We hypothesized that sequence data sampled within hosts using SGS would permit the detec-
tion of indels that have not yet been subject to substantial purifying selection. However, this
original hypothesis does not appear to be supported by our findings. As mentioned previously,
the minimal frameshift-inducing indel lengths found within hosts suggests strong purifying
selection still present at this scale. In further support of this, we find lower indel rates in the
terminal branches of phylogenetic trees demonstrating that lineages free from the constraint of
virus replication (i.e. terminals) still experience notable filtering of indel events, also implying
strong purifying selection.
My findings do however, support the “store and retrieve” hypothesis associated with HIV-1
evolution. This hypothesis describes the preferential transmission of an HIV-1 variant more
similar to the original founder virus than the highly-adapted variants in circulation, which
is a potential explanation for why HIV-1 exhibits faster evolution within hosts than among
hosts [5]. For instance, this apparent reversion of HIV-1 genetic diversity accounts for the
lower substitution rates observed among hosts relative to those within hosts [3, 7]. Similar
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to substitution rates, I postulate that this hypothesis also applies to my estimates of variable
loop indel rates. I hypothesize this based on the significantly higher rates within hosts, and
importantly, the identical trend in indel rates between variable loops (i.e. V1 and V5 being
highest, V2 and V4 next highest, and V3 lowest). Specifically, this identical trend in rates
suggests that within and among host sequence samples may undergo similar selection pressures
and patterns of indel accumulation, only that among-host rates exhibit lower magnitudes due
to selective “reversion” to an older, less mutated sequence upon transmission.
Finally, I have demonstrated that a two-state model system can be used to effectively cap-
ture and recreate trends in insertion sequence length and frequency. Specifically, I generated
an empirical model of insertions as the products of replication slippage that shows promise for
further expansion. In terms of effectiveness, my model is capable of simulating indels with
reasonably similar trends to observed data.
5.4 Significance & Contributions
This work provides an important contribution to the field of HIV-1 evolution by presenting
the first reported estimates of gene-specific indel evolution rates. For one, these rate estimates
describe biologically significant mutations in the gp120 variable loops, which are responsible
for the generation of immune escape variants and drive the adaptation of HIV-1 to human hosts.
Therefore, these rates can improve understanding of immune escape processes and may hold
correlations with disease progression, similar to evolutionary rates of substitutions. Indel rates
also quantify the contributions of indel to genetic sequence evolution in the gp120 variable
loops, allowing for comparisons to be made relative to nucleotide substitutions, for example.
Furthermore, our analysis of indel rates also marks an important step toward investigating the
potential for indels to be incorporated into phylogenetic inference, as current methods do not
account for this source of genetic information.
Beyond indel rates, my reports on indel-induced changes to variable loop PNGS provide
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novel quantified insights into the indel modulation of the glycan shield. Additionally, I con-
tribute an empirical model capable of recreating the trends in variable loop insertion sequences,
further demonstrating the viability and effectiveness of modelling indel mutations.
5.5 Future Directions
Future studies may consider further investigating indel timings and their association with im-
mune escape by examining correlations between gp120 variable loop characteristics and pa-
tient clinical outcomes. Such an approach could test the hypothesis that variable loop indels
and their rates of accumulation are in fact significant in a clinical context. Additionally, having
demonstrated the tractability of indel rate estimation among and within hosts, applying these
analyses to other areas of the HIV-1 genome is a sensible next step. The documentation of
additional indel rates could facilitate the development of efficient models of indel evolution
that allow indels to be utilized in phylogenetic inference methods. Moreover, by improving
understanding of the evolutionary landscape in gp120, my indel rate estimates might be useful
in future attempts at HIV-1 vaccine development, as these approaches would certainly need to
account for all aspects of evolution in gp120.
There is considerable work that can expand upon my empirical model of insertion se-
quences presented in Chapter 4. For one, the current mechanism of replication slippage can be
expanded to include deletion events in addition to insertions, possibly using a “jump ahead”
mechanism. Also, this model can be changed entirely to describe indels as products of a
template-switching mechanism instead. The slippage and template-switching models could
then be compared using model selection methods to determine which fits the data more effec-
tively, thereby offering insights into the likely underlying mechanisms driving indel generation.
In conclusion, I present my contributions to the topic of evolution in HIV-1 gp120 with
hopes to open up areas of future research into the rates, characteristics, and modelling of indels.
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Figure A1: The number of N-linked glycosylation sites in the variable loops of gp120.
Columns within each variable loop section describe the counts retrieved for one specific group
M clade. The color density of each box indicates the proportion of sequences containing the
given count. Examples of color densities and their corresponding proportions are provided by
the four boxes to the bottom left of the figure. Boxes containing a number highlight PNGS
counts that are above zero, but contained less than 10% of the distribution and therefore, did
not generate a noticeable color. Asterisks (*) and arrows denote the presence and direction of
significantly different PNGS counts among clades within a given variable loop (Poisson GLM).
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Figure A2: Log10-transformed genetic distances of cherries stratified by group M clade. Box
widths are representative of the number of cherries retrieved from the seven clades. Cherries
with zero genetic distance were excluded from this visualization. For each clade in the order
shown, counts of these filtered cherry pairs were 8, 0, 3, 203, 12, 6, and 1, respectively. Signifi-
cant differences in adjacent group means were determined using a Wilcoxon rank sum test after
adjusting for multiple comparisons and are indicated by * symbols. There were 68 instances
of cherries with a combined branch length of zero that contained an indel.
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A.2 Supplementary Tables
Estimate P Signif. Estimate P Signif.
Time 0.001 < 10−15 * Interactions
Clade F1:V2 -0.860 0.285
01 AE (reference) 02 AG:V3 -2.073 0.063
02 AG 1.946 0.058 A1:V3 0.127 0.799
A1 -0.103 0.741 B:V3 -0.381 0.255
B -1.156 1.6 × 10−10 * C:V3 -0.109 0.752
C -0.372 0.065 D:V3 1.363 0.017
D -0.639 0.070 F1:V3 -13.565 0.926
F1 -0.158 0.780 02 AG:V4 -2.441 0.027
Variable Region A1:V4 -0.099 0.819
V1 (reference) B:V4 -0.208 0.396
V2 -0.578 0.012 C:V4 -0.215 0.428
V3 -4.448 < 10−15 * D:V4 0.718 0.164
V4 -0.438 0.044 F1:V4 -0.577 0.439
V5 -0.042 0.844 02 AG:V5 -2.455 0.022
Interactions A1:V5 -0.569 0.151
02 AG:V2 -2.349 0.039 B:V5 0.194 0.407
A1:V2 -0.457 0.313 C:V5 0.246 0.345
B:V2 -0.918 4.1 × 10−4 * D:V5 -0.156 0.740
C:V2 -1.115 1.1 × 10−4 * F1:V5 -0.188 0.797
D:V2 -0.326 0.527
Table A1: Statistical comparisons generated by applying a generalized linear model to cherry
indel analysis. Comparisons made between clades and between variable regions were in rela-
tion to a reference group (01 AE and V1, respectively). Effects of clade and variable region
interactions were compared to predicted mean values to detect significant differences. Groups
with * symbols denoted statistically significant differences based on a Bonferroni-corrected
threshold suited for multiple comparisons (α = 0.05/n).
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Figure B1: Nucleotide proportions in insertions (a) and deletions (b) relative to the variable
loop sequences where they were recovered. Proportions of the four nucleotides, represented
by colors, are further stratified across the five gp120 variable loops as denoted by the different
shapes. Scales of the x and y axes are identical, meaning that points found above and below
the center line represent nucleotide proportions that are higher and lower in indels relative to
the variable loops, respectively.
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Figure B2: Dinucleotide proportions in insertions (a) and deletions (b) relative to their vari-
able loop sequences of origin. Proportions of all sixteen possible dinucleotides (A/C/G/T +
A/C/G/T ) pooled across all five gp120 variable loops are labelled by their name. As x and y
axes are identical, points above and below the line indicate dinucleotide proportions that are
higher and lower in indels relative to the variable loops, respectively.
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Figure B3: Posterior density of indel rate analysis on simulated data. Analysis was run for 105
MCMC iterations in the Bayesian statistical framework RStan to test accuracy of results. The
red line indicates the prior distribution while the black line at 0.03 indicates the true value used
to generate the simulated data.
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